TDMS No. P04: NEOPLASMS BY INDIVIDUAL ANIMAL Date …Date Report Reqsted: 06/15/2006 : Test Type: 26-WEEK : TEF TRANSGENICS (PECDF) Time Report Reqsted: 12:44:12 : Route:

Post on 24-Mar-2020

2 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

Transcript

TDMS No 20201 - 03

Test Type 26-WEEK

Route SKIN APPLICATION

SpeciesStrain MICETGAC HEMI

C Number

Lock Date

Cage Range

Date Range

Reasons For Removal

Removal Date Range

Treatment Groups

P04 NEOPLASMS BY INDIVIDUAL ANIMAL TEF TRANSGENICS (PECDF)

CAS Number 57117-31-4

Date Report Reqsted 06152006

Time Report Reqsted 124412

First Dose MF NA 042103

Lab BAT

C20201C

07242004

ALL

ALL

ALL

ALL

Include ALL

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 DAY ON TEST 8 8 8 8 8 8 8 6 8 8 8 7 8 8 8 8 8 8 8 8

7 3 5 5 6 6 5 5 6 3 5 4 7 1 3 4 6 6 4 4

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 0 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

ALIMENTARY SYSTEM

Liver + + + + + + + + + + + + + + + + + + + + 20

Leukemia Erythrocytic X 1

Mesentery + 1

Salivary Glands + 1

Squamous Cell Carcinoma X 1

Stomach Forestomach + + + + + + 6

Squamous Cell Papilloma X X X X 4

Squamous Cell Papilloma Multiple X 1

Stomach Glandular + 1

Tooth + + + + + + 6

Odontogenic Tumor X X X X X 5

Odontogenic Tumor Multiple X 1

CARDIOVASCULAR SYSTEM NONE

ENDOCRINE SYSTEM

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 2

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 DAY ON TEST 8 8 8 8 8 8 8 6 8 8 8 7 8 8 8 8 8 8 8 8

7 3 5 5 6 6 5 5 6 3 5 4 7 1 3 4 6 6 4 4

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 0 NGKG

NONE

GENERAL BODY SYSTEM NONE

GENITAL SYSTEM

Ovary

+ 1

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

HEMATOPOIETIC SYSTEM

Lymph Node Mesenteric + 1

Spleen + + + + + + + + + + + + + + + + + + + + 20

Leukemia Erythrocytic X 1

Thymus + + + + + + + + + + + + + + + + + + + + 20

INTEGUMENTARY SYSTEM

Skin + + + + 4

Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 3

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 DAY ON TEST 8 8 8 8 8 8 8 6 8 8 8 7 8 8 8 8 8 8 8 8

7 3 5 5 6 6 5 5 6 3 5 4 7 1 3 4 6 6 4 4

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 0 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

Squamous Cell Papilloma X 1

Skin Soa No Mass + + + + + + + + + + + + + + + + + + + + 20

MUSCULOSKELETAL SYSTEM NONE

NERVOUS SYSTEM NONE

RESPIRATORY SYSTEM

Lung

AlveolarBronchiolar Adenoma

Leukemia Erythrocytic

+ + + + + + + + + + + + + + + + + + + + 20

X 1 X 1

SPECIAL SENSES SYSTEM NONE

URINARY SYSTEM NONE

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 4

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 DAY ON TEST 8 8 8 8 8 8 8 6 8 8 8 7 8 8 8 8 8 8 8 8

7 3 5 5 6 6 5 5 6 3 5 4 7 1 3 4 6 6 4 4

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 0 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

SYSTEMIC LESIONS

Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 5

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 72 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

ALIMENTARY SYSTEM

Liver + + + + + + + + + + + + + + + + + + + + 20

Mesentery + 1

Pancreas + 1

Stomach Forestomach + + 2

Squamous Cell Papilloma X 1

Squamous Cell Papilloma Multiple X 1

Tooth + + + + + + 6

Odontogenic Tumor X X X X X 5

Odontogenic Tumor Multiple X 1

CARDIOVASCULAR SYSTEM NONE

ENDOCRINE SYSTEM NONE

GENERAL BODY SYSTEM NONE

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 6

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 72 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

GENITAL SYSTEM

Ovary + 1

HEMATOPOIETIC SYSTEM

Lymph Node Mandibular + 1

Lymph Node Mesenteric + 1

Spleen + + + + + + + + + + + + + + + + + + + + 20

Thymus + + + + + + + + + + + + + + + + + M + + 19

INTEGUMENTARY SYSTEM

Skin + + + + 4

Squamous Cell Papilloma X X X X 4

Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 7

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 72 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

Keratoacanthoma

Squamous Cell Carcinoma

Squamous Cell Papilloma

Squamous Cell Papilloma Multiple

Skin Soa No Mass

X 1 X 1

X X X X X 5 X X X X X X X X X X 10

+ + + + + + + + + + + + + + + + + + + + 20

MUSCULOSKELETAL SYSTEM NONE

NERVOUS SYSTEM NONE

RESPIRATORY SYSTEM

Lung

+ + + + + + + + + + + + + + + + + + + + 20

SPECIAL SENSES SYSTEM NONE

URINARY SYSTEM NONE

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 8

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 72 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

SYSTEMIC LESIONS

Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 9

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 242 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

ALIMENTARY SYSTEM

Liver + + + + + + + + + + + + + + + + + + + + 20

Stomach Forestomach + + 2

Squamous Cell Papilloma X 1

Squamous Cell Papilloma Multiple X 1

Tooth + + + 3

Odontogenic Tumor X X 2

CARDIOVASCULAR SYSTEM NONE

ENDOCRINE SYSTEM

Pituitary Gland

+ 1

GENERAL BODY SYSTEM NONE

GENITAL SYSTEM NONE

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 10

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 242 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

HEMATOPOIETIC SYSTEM

Spleen + + + + + + + + + + + + + + + + + + + + 20

Thymus + + + M + + + + + + + + + + + + + + + + 19

INTEGUMENTARY SYSTEM

Skin + + + + + + + + 8

Squamous Cell Papilloma X X X 3

Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

Spindle Cell Carcinoma X 1

Squamous Cell Carcinoma X X 2

Squamous Cell Papilloma X 1

Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16

Skin Soa No Mass + + + + + + + + + + + + + + + + + 17

MUSCULOSKELETAL SYSTEM

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 11

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 242 NGKG

NONE

NERVOUS SYSTEM NONE

RESPIRATORY SYSTEM

Lung

+ + + + + + + + + + + + + + + + + + + + 20

SPECIAL SENSES SYSTEM NONE

URINARY SYSTEM NONE

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

SYSTEMIC LESIONS

Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 12

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 720 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

ALIMENTARY SYSTEM

Liver + + + + + + + + + + + + + + + + + + + + 20

Leukemia Erythrocytic X 1

Stomach Forestomach + + + + + 5

Squamous Cell Papilloma X X X X X 5

Tooth + 1

CARDIOVASCULAR SYSTEM NONE

ENDOCRINE SYSTEM

Pituitary Gland

Leukemia Erythrocytic

+ 1 X 1

GENERAL BODY SYSTEM NONE

GENITAL SYSTEM NONE

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 13

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 720 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

HEMATOPOIETIC SYSTEM

Lymph Node + + + + + + + + 8

Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

Squamous Cell Carcinoma Metastatic X 1 Lymph Node

Squamous Cell Carcinoma Metastatic X X X 3 Skin

Lumbar Leukemia Erythrocytic X 1

Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin

Renal Leukemia Erythrocytic X 1

Lymph Node Mandibular + + + 3

Leukemia Erythrocytic X 1

Squamous Cell Carcinoma Metastatic X 1 Skin

Lymph Node Mesenteric + + 2

Spleen + + + + + + + + + + + + + + + + + + + + 20

Leukemia Erythrocytic X 1

Thymus + + + + + + + + + + + + + + + + + + + M 19

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 14

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 720 NGKG

0 0 3 4 1

0 0 3 4 2

0 0 3 4 3

0 0 3 4 4

0 0 3 4 5

0 0 3 4 6

0 0 3 4 7

0 0 3 4 8

0 0 3 4 9

0 0 3 5 0

0 0 3 5 1

0 0 3 5 2

0 0 3 5 3

0 0 3 5 4

0 0 3 5 5

0 0 3 5 6

0 0 3 5 7

0 0 3 5 8

0 0 3 5 9

0 0 3 6 0 TOTALS

INTEGUMENTARY SYSTEM

Skin + + + + + + + 7

Squamous Cell Papilloma X 1

Squamous Cell Papilloma Multiple X X X 3

Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

Keratoacanthoma X 1

Spindle Cell Carcinoma X 1

Squamous Cell Carcinoma X X X X X 5

Squamous Cell Carcinoma Multiple X X X X 4

Squamous Cell Papilloma X 1

Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

Skin Soa No Mass + + + + + + + + + + + + + 13

MUSCULOSKELETAL SYSTEM NONE

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 15

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 720 NGKG

NERVOUS SYSTEM NONE

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

RESPIRATORY SYSTEM

Lung + + + + + + + + + + + + + + + + + + + + 20

AlveolarBronchiolar Adenoma X 1

Leukemia Erythrocytic X 1

Squamous Cell Carcinoma Metastatic X 1 Skin

SPECIAL SENSES SYSTEM NONE

URINARY SYSTEM NONE

SYSTEMIC LESIONS

Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 16

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 1520 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

ALIMENTARY SYSTEM

Liver + + + + + + + + + + + + + + + + + + + + 20

Leukemia Granulocytic X 1

Stomach Forestomach + + + + + + + + 8

Squamous Cell Papilloma X X X X 4

Squamous Cell Papilloma Multiple X X X X 4

Tooth + + 2

Odontogenic Tumor X X 2

CARDIOVASCULAR SYSTEM

Blood Vessel + 1

Heart + 1

ENDOCRINE SYSTEM

Adrenal Cortex + 1

Adrenal Medulla + 1

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 17

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 1520 NGKG

GENERAL BODY SYSTEM NONE

GENITAL SYSTEM NONE

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

HEMATOPOIETIC SYSTEM

Bone Marrow + 1

Lymph Node + + + + 4

Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

Squamous Cell Carcinoma Metastatic X X X 3 Skin

Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

Lymph Node Mandibular + + + 3

Squamous Cell Carcinoma Metastatic X 1 Skin

Lymph Node Mesenteric + 1

Spleen + + + + + + + + + + + + + + + + + + + + 20

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 18

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 1520 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

Leukemia Granulocytic X 1

Thymus + + + M + + + + + + + + + + + M + + + + 18

INTEGUMENTARY SYSTEM

Skin + + + + + + + + + + + + + 13

Squamous Cell Papilloma X X X X X X X 7

Squamous Cell Papilloma Multiple X X X X X 5

Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

Spindle Cell Carcinoma X X X 3

Spindle Cell Carcinoma Multiple X 1

Squamous Cell Carcinoma X X X X X 5

Squamous Cell Carcinoma Multiple X X X X X X X 7

Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

Skin Soa No Mass + + + + + + + + + + + + 12

MUSCULOSKELETAL SYSTEM

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 19

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 1520 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

Bone + 1

NERVOUS SYSTEM

Brain + 1

RESPIRATORY SYSTEM

Lung + + + + + + + + + + + + + + + + + + + + 20

AlveolarBronchiolar Adenoma X 1

Leukemia Granulocytic X 1

Squamous Cell Carcinoma Metastatic X X 2 Skin

SPECIAL SENSES SYSTEM

Eye + 1

URINARY SYSTEM

Kidney + 1

Leukemia Granulocytic X 1

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 20

TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

SpeciesStrain MICETGAC HEMI Lab BAT

1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

TGAC (FVBN) HEMIZYGOUS MICE FEMALE

ANIMAL ID 1520 NGKG

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

SYSTEMIC LESIONS

Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

Myelodysplasia X 1

END OF REPORT

Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

Control data contained within this report was collected on study 20201-01 Page 21

  • TDMS No 20201 -03 P0413
  • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
  • END OF REPORT

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 DAY ON TEST 8 8 8 8 8 8 8 6 8 8 8 7 8 8 8 8 8 8 8 8

    7 3 5 5 6 6 5 5 6 3 5 4 7 1 3 4 6 6 4 4

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 0 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    ALIMENTARY SYSTEM

    Liver + + + + + + + + + + + + + + + + + + + + 20

    Leukemia Erythrocytic X 1

    Mesentery + 1

    Salivary Glands + 1

    Squamous Cell Carcinoma X 1

    Stomach Forestomach + + + + + + 6

    Squamous Cell Papilloma X X X X 4

    Squamous Cell Papilloma Multiple X 1

    Stomach Glandular + 1

    Tooth + + + + + + 6

    Odontogenic Tumor X X X X X 5

    Odontogenic Tumor Multiple X 1

    CARDIOVASCULAR SYSTEM NONE

    ENDOCRINE SYSTEM

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 2

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 DAY ON TEST 8 8 8 8 8 8 8 6 8 8 8 7 8 8 8 8 8 8 8 8

    7 3 5 5 6 6 5 5 6 3 5 4 7 1 3 4 6 6 4 4

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 0 NGKG

    NONE

    GENERAL BODY SYSTEM NONE

    GENITAL SYSTEM

    Ovary

    + 1

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    HEMATOPOIETIC SYSTEM

    Lymph Node Mesenteric + 1

    Spleen + + + + + + + + + + + + + + + + + + + + 20

    Leukemia Erythrocytic X 1

    Thymus + + + + + + + + + + + + + + + + + + + + 20

    INTEGUMENTARY SYSTEM

    Skin + + + + 4

    Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

    Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 3

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 DAY ON TEST 8 8 8 8 8 8 8 6 8 8 8 7 8 8 8 8 8 8 8 8

    7 3 5 5 6 6 5 5 6 3 5 4 7 1 3 4 6 6 4 4

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 0 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

    Squamous Cell Papilloma X 1

    Skin Soa No Mass + + + + + + + + + + + + + + + + + + + + 20

    MUSCULOSKELETAL SYSTEM NONE

    NERVOUS SYSTEM NONE

    RESPIRATORY SYSTEM

    Lung

    AlveolarBronchiolar Adenoma

    Leukemia Erythrocytic

    + + + + + + + + + + + + + + + + + + + + 20

    X 1 X 1

    SPECIAL SENSES SYSTEM NONE

    URINARY SYSTEM NONE

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 4

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 DAY ON TEST 8 8 8 8 8 8 8 6 8 8 8 7 8 8 8 8 8 8 8 8

    7 3 5 5 6 6 5 5 6 3 5 4 7 1 3 4 6 6 4 4

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 0 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    SYSTEMIC LESIONS

    Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 5

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

    3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 72 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    ALIMENTARY SYSTEM

    Liver + + + + + + + + + + + + + + + + + + + + 20

    Mesentery + 1

    Pancreas + 1

    Stomach Forestomach + + 2

    Squamous Cell Papilloma X 1

    Squamous Cell Papilloma Multiple X 1

    Tooth + + + + + + 6

    Odontogenic Tumor X X X X X 5

    Odontogenic Tumor Multiple X 1

    CARDIOVASCULAR SYSTEM NONE

    ENDOCRINE SYSTEM NONE

    GENERAL BODY SYSTEM NONE

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 6

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

    3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 72 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    GENITAL SYSTEM

    Ovary + 1

    HEMATOPOIETIC SYSTEM

    Lymph Node Mandibular + 1

    Lymph Node Mesenteric + 1

    Spleen + + + + + + + + + + + + + + + + + + + + 20

    Thymus + + + + + + + + + + + + + + + + + M + + 19

    INTEGUMENTARY SYSTEM

    Skin + + + + 4

    Squamous Cell Papilloma X X X X 4

    Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

    Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

    Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 7

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

    3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 72 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    Keratoacanthoma

    Squamous Cell Carcinoma

    Squamous Cell Papilloma

    Squamous Cell Papilloma Multiple

    Skin Soa No Mass

    X 1 X 1

    X X X X X 5 X X X X X X X X X X 10

    + + + + + + + + + + + + + + + + + + + + 20

    MUSCULOSKELETAL SYSTEM NONE

    NERVOUS SYSTEM NONE

    RESPIRATORY SYSTEM

    Lung

    + + + + + + + + + + + + + + + + + + + + 20

    SPECIAL SENSES SYSTEM NONE

    URINARY SYSTEM NONE

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 8

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

    3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 72 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    SYSTEMIC LESIONS

    Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 9

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

    3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 242 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    ALIMENTARY SYSTEM

    Liver + + + + + + + + + + + + + + + + + + + + 20

    Stomach Forestomach + + 2

    Squamous Cell Papilloma X 1

    Squamous Cell Papilloma Multiple X 1

    Tooth + + + 3

    Odontogenic Tumor X X 2

    CARDIOVASCULAR SYSTEM NONE

    ENDOCRINE SYSTEM

    Pituitary Gland

    + 1

    GENERAL BODY SYSTEM NONE

    GENITAL SYSTEM NONE

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 10

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

    3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 242 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    HEMATOPOIETIC SYSTEM

    Spleen + + + + + + + + + + + + + + + + + + + + 20

    Thymus + + + M + + + + + + + + + + + + + + + + 19

    INTEGUMENTARY SYSTEM

    Skin + + + + + + + + 8

    Squamous Cell Papilloma X X X 3

    Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

    Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

    Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

    Spindle Cell Carcinoma X 1

    Squamous Cell Carcinoma X X 2

    Squamous Cell Papilloma X 1

    Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16

    Skin Soa No Mass + + + + + + + + + + + + + + + + + 17

    MUSCULOSKELETAL SYSTEM

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 11

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

    3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 242 NGKG

    NONE

    NERVOUS SYSTEM NONE

    RESPIRATORY SYSTEM

    Lung

    + + + + + + + + + + + + + + + + + + + + 20

    SPECIAL SENSES SYSTEM NONE

    URINARY SYSTEM NONE

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    SYSTEMIC LESIONS

    Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 12

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

    0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 720 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    ALIMENTARY SYSTEM

    Liver + + + + + + + + + + + + + + + + + + + + 20

    Leukemia Erythrocytic X 1

    Stomach Forestomach + + + + + 5

    Squamous Cell Papilloma X X X X X 5

    Tooth + 1

    CARDIOVASCULAR SYSTEM NONE

    ENDOCRINE SYSTEM

    Pituitary Gland

    Leukemia Erythrocytic

    + 1 X 1

    GENERAL BODY SYSTEM NONE

    GENITAL SYSTEM NONE

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 13

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

    0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 720 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    HEMATOPOIETIC SYSTEM

    Lymph Node + + + + + + + + 8

    Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

    Squamous Cell Carcinoma Metastatic X 1 Lymph Node

    Squamous Cell Carcinoma Metastatic X X X 3 Skin

    Lumbar Leukemia Erythrocytic X 1

    Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin

    Renal Leukemia Erythrocytic X 1

    Lymph Node Mandibular + + + 3

    Leukemia Erythrocytic X 1

    Squamous Cell Carcinoma Metastatic X 1 Skin

    Lymph Node Mesenteric + + 2

    Spleen + + + + + + + + + + + + + + + + + + + + 20

    Leukemia Erythrocytic X 1

    Thymus + + + + + + + + + + + + + + + + + + + M 19

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 14

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 720 NGKG

    0 0 3 4 1

    0 0 3 4 2

    0 0 3 4 3

    0 0 3 4 4

    0 0 3 4 5

    0 0 3 4 6

    0 0 3 4 7

    0 0 3 4 8

    0 0 3 4 9

    0 0 3 5 0

    0 0 3 5 1

    0 0 3 5 2

    0 0 3 5 3

    0 0 3 5 4

    0 0 3 5 5

    0 0 3 5 6

    0 0 3 5 7

    0 0 3 5 8

    0 0 3 5 9

    0 0 3 6 0 TOTALS

    INTEGUMENTARY SYSTEM

    Skin + + + + + + + 7

    Squamous Cell Papilloma X 1

    Squamous Cell Papilloma Multiple X X X 3

    Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

    Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

    Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

    Keratoacanthoma X 1

    Spindle Cell Carcinoma X 1

    Squamous Cell Carcinoma X X X X X 5

    Squamous Cell Carcinoma Multiple X X X X 4

    Squamous Cell Papilloma X 1

    Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

    Skin Soa No Mass + + + + + + + + + + + + + 13

    MUSCULOSKELETAL SYSTEM NONE

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 15

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

    0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 720 NGKG

    NERVOUS SYSTEM NONE

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    RESPIRATORY SYSTEM

    Lung + + + + + + + + + + + + + + + + + + + + 20

    AlveolarBronchiolar Adenoma X 1

    Leukemia Erythrocytic X 1

    Squamous Cell Carcinoma Metastatic X 1 Skin

    SPECIAL SENSES SYSTEM NONE

    URINARY SYSTEM NONE

    SYSTEMIC LESIONS

    Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 16

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

    5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 1520 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    ALIMENTARY SYSTEM

    Liver + + + + + + + + + + + + + + + + + + + + 20

    Leukemia Granulocytic X 1

    Stomach Forestomach + + + + + + + + 8

    Squamous Cell Papilloma X X X X 4

    Squamous Cell Papilloma Multiple X X X X 4

    Tooth + + 2

    Odontogenic Tumor X X 2

    CARDIOVASCULAR SYSTEM

    Blood Vessel + 1

    Heart + 1

    ENDOCRINE SYSTEM

    Adrenal Cortex + 1

    Adrenal Medulla + 1

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 17

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

    5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 1520 NGKG

    GENERAL BODY SYSTEM NONE

    GENITAL SYSTEM NONE

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    HEMATOPOIETIC SYSTEM

    Bone Marrow + 1

    Lymph Node + + + + 4

    Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

    Squamous Cell Carcinoma Metastatic X X X 3 Skin

    Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

    Lymph Node Mandibular + + + 3

    Squamous Cell Carcinoma Metastatic X 1 Skin

    Lymph Node Mesenteric + 1

    Spleen + + + + + + + + + + + + + + + + + + + + 20

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 18

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

    5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 1520 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    Leukemia Granulocytic X 1

    Thymus + + + M + + + + + + + + + + + M + + + + 18

    INTEGUMENTARY SYSTEM

    Skin + + + + + + + + + + + + + 13

    Squamous Cell Papilloma X X X X X X X 7

    Squamous Cell Papilloma Multiple X X X X X 5

    Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

    Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

    Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

    Spindle Cell Carcinoma X X X 3

    Spindle Cell Carcinoma Multiple X 1

    Squamous Cell Carcinoma X X X X X 5

    Squamous Cell Carcinoma Multiple X X X X X X X 7

    Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

    Skin Soa No Mass + + + + + + + + + + + + 12

    MUSCULOSKELETAL SYSTEM

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 19

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

    5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 1520 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    Bone + 1

    NERVOUS SYSTEM

    Brain + 1

    RESPIRATORY SYSTEM

    Lung + + + + + + + + + + + + + + + + + + + + 20

    AlveolarBronchiolar Adenoma X 1

    Leukemia Granulocytic X 1

    Squamous Cell Carcinoma Metastatic X X 2 Skin

    SPECIAL SENSES SYSTEM

    Eye + 1

    URINARY SYSTEM

    Kidney + 1

    Leukemia Granulocytic X 1

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 20

    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

    SpeciesStrain MICETGAC HEMI Lab BAT

    1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

    5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

    ANIMAL ID 1520 NGKG

    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

    SYSTEMIC LESIONS

    Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

    Myelodysplasia X 1

    END OF REPORT

    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

    Control data contained within this report was collected on study 20201-01 Page 21

    • TDMS No 20201 -03 P0413
    • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
    • END OF REPORT

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 DAY ON TEST 8 8 8 8 8 8 8 6 8 8 8 7 8 8 8 8 8 8 8 8

      7 3 5 5 6 6 5 5 6 3 5 4 7 1 3 4 6 6 4 4

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 0 NGKG

      NONE

      GENERAL BODY SYSTEM NONE

      GENITAL SYSTEM

      Ovary

      + 1

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      HEMATOPOIETIC SYSTEM

      Lymph Node Mesenteric + 1

      Spleen + + + + + + + + + + + + + + + + + + + + 20

      Leukemia Erythrocytic X 1

      Thymus + + + + + + + + + + + + + + + + + + + + 20

      INTEGUMENTARY SYSTEM

      Skin + + + + 4

      Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

      Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 3

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 DAY ON TEST 8 8 8 8 8 8 8 6 8 8 8 7 8 8 8 8 8 8 8 8

      7 3 5 5 6 6 5 5 6 3 5 4 7 1 3 4 6 6 4 4

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 0 NGKG

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

      Squamous Cell Papilloma X 1

      Skin Soa No Mass + + + + + + + + + + + + + + + + + + + + 20

      MUSCULOSKELETAL SYSTEM NONE

      NERVOUS SYSTEM NONE

      RESPIRATORY SYSTEM

      Lung

      AlveolarBronchiolar Adenoma

      Leukemia Erythrocytic

      + + + + + + + + + + + + + + + + + + + + 20

      X 1 X 1

      SPECIAL SENSES SYSTEM NONE

      URINARY SYSTEM NONE

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 4

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 DAY ON TEST 8 8 8 8 8 8 8 6 8 8 8 7 8 8 8 8 8 8 8 8

      7 3 5 5 6 6 5 5 6 3 5 4 7 1 3 4 6 6 4 4

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 0 NGKG

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      SYSTEMIC LESIONS

      Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 5

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

      3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 72 NGKG

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      ALIMENTARY SYSTEM

      Liver + + + + + + + + + + + + + + + + + + + + 20

      Mesentery + 1

      Pancreas + 1

      Stomach Forestomach + + 2

      Squamous Cell Papilloma X 1

      Squamous Cell Papilloma Multiple X 1

      Tooth + + + + + + 6

      Odontogenic Tumor X X X X X 5

      Odontogenic Tumor Multiple X 1

      CARDIOVASCULAR SYSTEM NONE

      ENDOCRINE SYSTEM NONE

      GENERAL BODY SYSTEM NONE

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 6

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

      3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 72 NGKG

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      GENITAL SYSTEM

      Ovary + 1

      HEMATOPOIETIC SYSTEM

      Lymph Node Mandibular + 1

      Lymph Node Mesenteric + 1

      Spleen + + + + + + + + + + + + + + + + + + + + 20

      Thymus + + + + + + + + + + + + + + + + + M + + 19

      INTEGUMENTARY SYSTEM

      Skin + + + + 4

      Squamous Cell Papilloma X X X X 4

      Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

      Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

      Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 7

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

      3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 72 NGKG

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      Keratoacanthoma

      Squamous Cell Carcinoma

      Squamous Cell Papilloma

      Squamous Cell Papilloma Multiple

      Skin Soa No Mass

      X 1 X 1

      X X X X X 5 X X X X X X X X X X 10

      + + + + + + + + + + + + + + + + + + + + 20

      MUSCULOSKELETAL SYSTEM NONE

      NERVOUS SYSTEM NONE

      RESPIRATORY SYSTEM

      Lung

      + + + + + + + + + + + + + + + + + + + + 20

      SPECIAL SENSES SYSTEM NONE

      URINARY SYSTEM NONE

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 8

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

      3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 72 NGKG

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      SYSTEMIC LESIONS

      Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 9

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

      3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 242 NGKG

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      ALIMENTARY SYSTEM

      Liver + + + + + + + + + + + + + + + + + + + + 20

      Stomach Forestomach + + 2

      Squamous Cell Papilloma X 1

      Squamous Cell Papilloma Multiple X 1

      Tooth + + + 3

      Odontogenic Tumor X X 2

      CARDIOVASCULAR SYSTEM NONE

      ENDOCRINE SYSTEM

      Pituitary Gland

      + 1

      GENERAL BODY SYSTEM NONE

      GENITAL SYSTEM NONE

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 10

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

      3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 242 NGKG

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      HEMATOPOIETIC SYSTEM

      Spleen + + + + + + + + + + + + + + + + + + + + 20

      Thymus + + + M + + + + + + + + + + + + + + + + 19

      INTEGUMENTARY SYSTEM

      Skin + + + + + + + + 8

      Squamous Cell Papilloma X X X 3

      Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

      Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

      Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

      Spindle Cell Carcinoma X 1

      Squamous Cell Carcinoma X X 2

      Squamous Cell Papilloma X 1

      Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16

      Skin Soa No Mass + + + + + + + + + + + + + + + + + 17

      MUSCULOSKELETAL SYSTEM

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 11

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

      3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 242 NGKG

      NONE

      NERVOUS SYSTEM NONE

      RESPIRATORY SYSTEM

      Lung

      + + + + + + + + + + + + + + + + + + + + 20

      SPECIAL SENSES SYSTEM NONE

      URINARY SYSTEM NONE

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      SYSTEMIC LESIONS

      Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 12

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

      0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 720 NGKG

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      ALIMENTARY SYSTEM

      Liver + + + + + + + + + + + + + + + + + + + + 20

      Leukemia Erythrocytic X 1

      Stomach Forestomach + + + + + 5

      Squamous Cell Papilloma X X X X X 5

      Tooth + 1

      CARDIOVASCULAR SYSTEM NONE

      ENDOCRINE SYSTEM

      Pituitary Gland

      Leukemia Erythrocytic

      + 1 X 1

      GENERAL BODY SYSTEM NONE

      GENITAL SYSTEM NONE

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 13

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

      0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 720 NGKG

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      HEMATOPOIETIC SYSTEM

      Lymph Node + + + + + + + + 8

      Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

      Squamous Cell Carcinoma Metastatic X 1 Lymph Node

      Squamous Cell Carcinoma Metastatic X X X 3 Skin

      Lumbar Leukemia Erythrocytic X 1

      Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin

      Renal Leukemia Erythrocytic X 1

      Lymph Node Mandibular + + + 3

      Leukemia Erythrocytic X 1

      Squamous Cell Carcinoma Metastatic X 1 Skin

      Lymph Node Mesenteric + + 2

      Spleen + + + + + + + + + + + + + + + + + + + + 20

      Leukemia Erythrocytic X 1

      Thymus + + + + + + + + + + + + + + + + + + + M 19

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 14

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 720 NGKG

      0 0 3 4 1

      0 0 3 4 2

      0 0 3 4 3

      0 0 3 4 4

      0 0 3 4 5

      0 0 3 4 6

      0 0 3 4 7

      0 0 3 4 8

      0 0 3 4 9

      0 0 3 5 0

      0 0 3 5 1

      0 0 3 5 2

      0 0 3 5 3

      0 0 3 5 4

      0 0 3 5 5

      0 0 3 5 6

      0 0 3 5 7

      0 0 3 5 8

      0 0 3 5 9

      0 0 3 6 0 TOTALS

      INTEGUMENTARY SYSTEM

      Skin + + + + + + + 7

      Squamous Cell Papilloma X 1

      Squamous Cell Papilloma Multiple X X X 3

      Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

      Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

      Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

      Keratoacanthoma X 1

      Spindle Cell Carcinoma X 1

      Squamous Cell Carcinoma X X X X X 5

      Squamous Cell Carcinoma Multiple X X X X 4

      Squamous Cell Papilloma X 1

      Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

      Skin Soa No Mass + + + + + + + + + + + + + 13

      MUSCULOSKELETAL SYSTEM NONE

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 15

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

      0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 720 NGKG

      NERVOUS SYSTEM NONE

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      RESPIRATORY SYSTEM

      Lung + + + + + + + + + + + + + + + + + + + + 20

      AlveolarBronchiolar Adenoma X 1

      Leukemia Erythrocytic X 1

      Squamous Cell Carcinoma Metastatic X 1 Skin

      SPECIAL SENSES SYSTEM NONE

      URINARY SYSTEM NONE

      SYSTEMIC LESIONS

      Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 16

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

      5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 1520 NGKG

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      ALIMENTARY SYSTEM

      Liver + + + + + + + + + + + + + + + + + + + + 20

      Leukemia Granulocytic X 1

      Stomach Forestomach + + + + + + + + 8

      Squamous Cell Papilloma X X X X 4

      Squamous Cell Papilloma Multiple X X X X 4

      Tooth + + 2

      Odontogenic Tumor X X 2

      CARDIOVASCULAR SYSTEM

      Blood Vessel + 1

      Heart + 1

      ENDOCRINE SYSTEM

      Adrenal Cortex + 1

      Adrenal Medulla + 1

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 17

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

      5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 1520 NGKG

      GENERAL BODY SYSTEM NONE

      GENITAL SYSTEM NONE

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      HEMATOPOIETIC SYSTEM

      Bone Marrow + 1

      Lymph Node + + + + 4

      Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

      Squamous Cell Carcinoma Metastatic X X X 3 Skin

      Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

      Lymph Node Mandibular + + + 3

      Squamous Cell Carcinoma Metastatic X 1 Skin

      Lymph Node Mesenteric + 1

      Spleen + + + + + + + + + + + + + + + + + + + + 20

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 18

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

      5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 1520 NGKG

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      Leukemia Granulocytic X 1

      Thymus + + + M + + + + + + + + + + + M + + + + 18

      INTEGUMENTARY SYSTEM

      Skin + + + + + + + + + + + + + 13

      Squamous Cell Papilloma X X X X X X X 7

      Squamous Cell Papilloma Multiple X X X X X 5

      Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

      Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

      Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

      Spindle Cell Carcinoma X X X 3

      Spindle Cell Carcinoma Multiple X 1

      Squamous Cell Carcinoma X X X X X 5

      Squamous Cell Carcinoma Multiple X X X X X X X 7

      Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

      Skin Soa No Mass + + + + + + + + + + + + 12

      MUSCULOSKELETAL SYSTEM

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 19

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

      5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 1520 NGKG

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      Bone + 1

      NERVOUS SYSTEM

      Brain + 1

      RESPIRATORY SYSTEM

      Lung + + + + + + + + + + + + + + + + + + + + 20

      AlveolarBronchiolar Adenoma X 1

      Leukemia Granulocytic X 1

      Squamous Cell Carcinoma Metastatic X X 2 Skin

      SPECIAL SENSES SYSTEM

      Eye + 1

      URINARY SYSTEM

      Kidney + 1

      Leukemia Granulocytic X 1

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 20

      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

      SpeciesStrain MICETGAC HEMI Lab BAT

      1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

      5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

      ANIMAL ID 1520 NGKG

      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

      SYSTEMIC LESIONS

      Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

      Myelodysplasia X 1

      END OF REPORT

      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

      Control data contained within this report was collected on study 20201-01 Page 21

      • TDMS No 20201 -03 P0413
      • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
      • END OF REPORT

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 DAY ON TEST 8 8 8 8 8 8 8 6 8 8 8 7 8 8 8 8 8 8 8 8

        7 3 5 5 6 6 5 5 6 3 5 4 7 1 3 4 6 6 4 4

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 0 NGKG

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

        Squamous Cell Papilloma X 1

        Skin Soa No Mass + + + + + + + + + + + + + + + + + + + + 20

        MUSCULOSKELETAL SYSTEM NONE

        NERVOUS SYSTEM NONE

        RESPIRATORY SYSTEM

        Lung

        AlveolarBronchiolar Adenoma

        Leukemia Erythrocytic

        + + + + + + + + + + + + + + + + + + + + 20

        X 1 X 1

        SPECIAL SENSES SYSTEM NONE

        URINARY SYSTEM NONE

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 4

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 DAY ON TEST 8 8 8 8 8 8 8 6 8 8 8 7 8 8 8 8 8 8 8 8

        7 3 5 5 6 6 5 5 6 3 5 4 7 1 3 4 6 6 4 4

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 0 NGKG

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        SYSTEMIC LESIONS

        Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 5

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

        3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 72 NGKG

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        ALIMENTARY SYSTEM

        Liver + + + + + + + + + + + + + + + + + + + + 20

        Mesentery + 1

        Pancreas + 1

        Stomach Forestomach + + 2

        Squamous Cell Papilloma X 1

        Squamous Cell Papilloma Multiple X 1

        Tooth + + + + + + 6

        Odontogenic Tumor X X X X X 5

        Odontogenic Tumor Multiple X 1

        CARDIOVASCULAR SYSTEM NONE

        ENDOCRINE SYSTEM NONE

        GENERAL BODY SYSTEM NONE

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 6

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

        3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 72 NGKG

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        GENITAL SYSTEM

        Ovary + 1

        HEMATOPOIETIC SYSTEM

        Lymph Node Mandibular + 1

        Lymph Node Mesenteric + 1

        Spleen + + + + + + + + + + + + + + + + + + + + 20

        Thymus + + + + + + + + + + + + + + + + + M + + 19

        INTEGUMENTARY SYSTEM

        Skin + + + + 4

        Squamous Cell Papilloma X X X X 4

        Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

        Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

        Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 7

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

        3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 72 NGKG

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        Keratoacanthoma

        Squamous Cell Carcinoma

        Squamous Cell Papilloma

        Squamous Cell Papilloma Multiple

        Skin Soa No Mass

        X 1 X 1

        X X X X X 5 X X X X X X X X X X 10

        + + + + + + + + + + + + + + + + + + + + 20

        MUSCULOSKELETAL SYSTEM NONE

        NERVOUS SYSTEM NONE

        RESPIRATORY SYSTEM

        Lung

        + + + + + + + + + + + + + + + + + + + + 20

        SPECIAL SENSES SYSTEM NONE

        URINARY SYSTEM NONE

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 8

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

        3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 72 NGKG

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        SYSTEMIC LESIONS

        Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 9

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

        3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 242 NGKG

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        ALIMENTARY SYSTEM

        Liver + + + + + + + + + + + + + + + + + + + + 20

        Stomach Forestomach + + 2

        Squamous Cell Papilloma X 1

        Squamous Cell Papilloma Multiple X 1

        Tooth + + + 3

        Odontogenic Tumor X X 2

        CARDIOVASCULAR SYSTEM NONE

        ENDOCRINE SYSTEM

        Pituitary Gland

        + 1

        GENERAL BODY SYSTEM NONE

        GENITAL SYSTEM NONE

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 10

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

        3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 242 NGKG

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        HEMATOPOIETIC SYSTEM

        Spleen + + + + + + + + + + + + + + + + + + + + 20

        Thymus + + + M + + + + + + + + + + + + + + + + 19

        INTEGUMENTARY SYSTEM

        Skin + + + + + + + + 8

        Squamous Cell Papilloma X X X 3

        Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

        Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

        Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

        Spindle Cell Carcinoma X 1

        Squamous Cell Carcinoma X X 2

        Squamous Cell Papilloma X 1

        Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16

        Skin Soa No Mass + + + + + + + + + + + + + + + + + 17

        MUSCULOSKELETAL SYSTEM

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 11

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

        3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 242 NGKG

        NONE

        NERVOUS SYSTEM NONE

        RESPIRATORY SYSTEM

        Lung

        + + + + + + + + + + + + + + + + + + + + 20

        SPECIAL SENSES SYSTEM NONE

        URINARY SYSTEM NONE

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        SYSTEMIC LESIONS

        Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 12

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

        0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 720 NGKG

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        ALIMENTARY SYSTEM

        Liver + + + + + + + + + + + + + + + + + + + + 20

        Leukemia Erythrocytic X 1

        Stomach Forestomach + + + + + 5

        Squamous Cell Papilloma X X X X X 5

        Tooth + 1

        CARDIOVASCULAR SYSTEM NONE

        ENDOCRINE SYSTEM

        Pituitary Gland

        Leukemia Erythrocytic

        + 1 X 1

        GENERAL BODY SYSTEM NONE

        GENITAL SYSTEM NONE

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 13

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

        0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 720 NGKG

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        HEMATOPOIETIC SYSTEM

        Lymph Node + + + + + + + + 8

        Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

        Squamous Cell Carcinoma Metastatic X 1 Lymph Node

        Squamous Cell Carcinoma Metastatic X X X 3 Skin

        Lumbar Leukemia Erythrocytic X 1

        Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin

        Renal Leukemia Erythrocytic X 1

        Lymph Node Mandibular + + + 3

        Leukemia Erythrocytic X 1

        Squamous Cell Carcinoma Metastatic X 1 Skin

        Lymph Node Mesenteric + + 2

        Spleen + + + + + + + + + + + + + + + + + + + + 20

        Leukemia Erythrocytic X 1

        Thymus + + + + + + + + + + + + + + + + + + + M 19

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 14

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 720 NGKG

        0 0 3 4 1

        0 0 3 4 2

        0 0 3 4 3

        0 0 3 4 4

        0 0 3 4 5

        0 0 3 4 6

        0 0 3 4 7

        0 0 3 4 8

        0 0 3 4 9

        0 0 3 5 0

        0 0 3 5 1

        0 0 3 5 2

        0 0 3 5 3

        0 0 3 5 4

        0 0 3 5 5

        0 0 3 5 6

        0 0 3 5 7

        0 0 3 5 8

        0 0 3 5 9

        0 0 3 6 0 TOTALS

        INTEGUMENTARY SYSTEM

        Skin + + + + + + + 7

        Squamous Cell Papilloma X 1

        Squamous Cell Papilloma Multiple X X X 3

        Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

        Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

        Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

        Keratoacanthoma X 1

        Spindle Cell Carcinoma X 1

        Squamous Cell Carcinoma X X X X X 5

        Squamous Cell Carcinoma Multiple X X X X 4

        Squamous Cell Papilloma X 1

        Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

        Skin Soa No Mass + + + + + + + + + + + + + 13

        MUSCULOSKELETAL SYSTEM NONE

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 15

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

        0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 720 NGKG

        NERVOUS SYSTEM NONE

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        RESPIRATORY SYSTEM

        Lung + + + + + + + + + + + + + + + + + + + + 20

        AlveolarBronchiolar Adenoma X 1

        Leukemia Erythrocytic X 1

        Squamous Cell Carcinoma Metastatic X 1 Skin

        SPECIAL SENSES SYSTEM NONE

        URINARY SYSTEM NONE

        SYSTEMIC LESIONS

        Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 16

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

        5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 1520 NGKG

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        ALIMENTARY SYSTEM

        Liver + + + + + + + + + + + + + + + + + + + + 20

        Leukemia Granulocytic X 1

        Stomach Forestomach + + + + + + + + 8

        Squamous Cell Papilloma X X X X 4

        Squamous Cell Papilloma Multiple X X X X 4

        Tooth + + 2

        Odontogenic Tumor X X 2

        CARDIOVASCULAR SYSTEM

        Blood Vessel + 1

        Heart + 1

        ENDOCRINE SYSTEM

        Adrenal Cortex + 1

        Adrenal Medulla + 1

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 17

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

        5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 1520 NGKG

        GENERAL BODY SYSTEM NONE

        GENITAL SYSTEM NONE

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        HEMATOPOIETIC SYSTEM

        Bone Marrow + 1

        Lymph Node + + + + 4

        Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

        Squamous Cell Carcinoma Metastatic X X X 3 Skin

        Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

        Lymph Node Mandibular + + + 3

        Squamous Cell Carcinoma Metastatic X 1 Skin

        Lymph Node Mesenteric + 1

        Spleen + + + + + + + + + + + + + + + + + + + + 20

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 18

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

        5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 1520 NGKG

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        Leukemia Granulocytic X 1

        Thymus + + + M + + + + + + + + + + + M + + + + 18

        INTEGUMENTARY SYSTEM

        Skin + + + + + + + + + + + + + 13

        Squamous Cell Papilloma X X X X X X X 7

        Squamous Cell Papilloma Multiple X X X X X 5

        Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

        Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

        Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

        Spindle Cell Carcinoma X X X 3

        Spindle Cell Carcinoma Multiple X 1

        Squamous Cell Carcinoma X X X X X 5

        Squamous Cell Carcinoma Multiple X X X X X X X 7

        Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

        Skin Soa No Mass + + + + + + + + + + + + 12

        MUSCULOSKELETAL SYSTEM

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 19

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

        5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 1520 NGKG

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        Bone + 1

        NERVOUS SYSTEM

        Brain + 1

        RESPIRATORY SYSTEM

        Lung + + + + + + + + + + + + + + + + + + + + 20

        AlveolarBronchiolar Adenoma X 1

        Leukemia Granulocytic X 1

        Squamous Cell Carcinoma Metastatic X X 2 Skin

        SPECIAL SENSES SYSTEM

        Eye + 1

        URINARY SYSTEM

        Kidney + 1

        Leukemia Granulocytic X 1

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 20

        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

        SpeciesStrain MICETGAC HEMI Lab BAT

        1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

        5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

        ANIMAL ID 1520 NGKG

        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

        SYSTEMIC LESIONS

        Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

        Myelodysplasia X 1

        END OF REPORT

        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

        Control data contained within this report was collected on study 20201-01 Page 21

        • TDMS No 20201 -03 P0413
        • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
        • END OF REPORT

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 DAY ON TEST 8 8 8 8 8 8 8 6 8 8 8 7 8 8 8 8 8 8 8 8

          7 3 5 5 6 6 5 5 6 3 5 4 7 1 3 4 6 6 4 4

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 0 NGKG

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          SYSTEMIC LESIONS

          Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 5

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

          3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 72 NGKG

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          ALIMENTARY SYSTEM

          Liver + + + + + + + + + + + + + + + + + + + + 20

          Mesentery + 1

          Pancreas + 1

          Stomach Forestomach + + 2

          Squamous Cell Papilloma X 1

          Squamous Cell Papilloma Multiple X 1

          Tooth + + + + + + 6

          Odontogenic Tumor X X X X X 5

          Odontogenic Tumor Multiple X 1

          CARDIOVASCULAR SYSTEM NONE

          ENDOCRINE SYSTEM NONE

          GENERAL BODY SYSTEM NONE

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 6

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

          3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 72 NGKG

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          GENITAL SYSTEM

          Ovary + 1

          HEMATOPOIETIC SYSTEM

          Lymph Node Mandibular + 1

          Lymph Node Mesenteric + 1

          Spleen + + + + + + + + + + + + + + + + + + + + 20

          Thymus + + + + + + + + + + + + + + + + + M + + 19

          INTEGUMENTARY SYSTEM

          Skin + + + + 4

          Squamous Cell Papilloma X X X X 4

          Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

          Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

          Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 7

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

          3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 72 NGKG

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          Keratoacanthoma

          Squamous Cell Carcinoma

          Squamous Cell Papilloma

          Squamous Cell Papilloma Multiple

          Skin Soa No Mass

          X 1 X 1

          X X X X X 5 X X X X X X X X X X 10

          + + + + + + + + + + + + + + + + + + + + 20

          MUSCULOSKELETAL SYSTEM NONE

          NERVOUS SYSTEM NONE

          RESPIRATORY SYSTEM

          Lung

          + + + + + + + + + + + + + + + + + + + + 20

          SPECIAL SENSES SYSTEM NONE

          URINARY SYSTEM NONE

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 8

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

          3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 72 NGKG

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          SYSTEMIC LESIONS

          Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 9

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

          3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 242 NGKG

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          ALIMENTARY SYSTEM

          Liver + + + + + + + + + + + + + + + + + + + + 20

          Stomach Forestomach + + 2

          Squamous Cell Papilloma X 1

          Squamous Cell Papilloma Multiple X 1

          Tooth + + + 3

          Odontogenic Tumor X X 2

          CARDIOVASCULAR SYSTEM NONE

          ENDOCRINE SYSTEM

          Pituitary Gland

          + 1

          GENERAL BODY SYSTEM NONE

          GENITAL SYSTEM NONE

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 10

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

          3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 242 NGKG

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          HEMATOPOIETIC SYSTEM

          Spleen + + + + + + + + + + + + + + + + + + + + 20

          Thymus + + + M + + + + + + + + + + + + + + + + 19

          INTEGUMENTARY SYSTEM

          Skin + + + + + + + + 8

          Squamous Cell Papilloma X X X 3

          Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

          Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

          Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

          Spindle Cell Carcinoma X 1

          Squamous Cell Carcinoma X X 2

          Squamous Cell Papilloma X 1

          Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16

          Skin Soa No Mass + + + + + + + + + + + + + + + + + 17

          MUSCULOSKELETAL SYSTEM

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 11

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

          3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 242 NGKG

          NONE

          NERVOUS SYSTEM NONE

          RESPIRATORY SYSTEM

          Lung

          + + + + + + + + + + + + + + + + + + + + 20

          SPECIAL SENSES SYSTEM NONE

          URINARY SYSTEM NONE

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          SYSTEMIC LESIONS

          Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 12

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

          0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 720 NGKG

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          ALIMENTARY SYSTEM

          Liver + + + + + + + + + + + + + + + + + + + + 20

          Leukemia Erythrocytic X 1

          Stomach Forestomach + + + + + 5

          Squamous Cell Papilloma X X X X X 5

          Tooth + 1

          CARDIOVASCULAR SYSTEM NONE

          ENDOCRINE SYSTEM

          Pituitary Gland

          Leukemia Erythrocytic

          + 1 X 1

          GENERAL BODY SYSTEM NONE

          GENITAL SYSTEM NONE

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 13

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

          0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 720 NGKG

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          HEMATOPOIETIC SYSTEM

          Lymph Node + + + + + + + + 8

          Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

          Squamous Cell Carcinoma Metastatic X 1 Lymph Node

          Squamous Cell Carcinoma Metastatic X X X 3 Skin

          Lumbar Leukemia Erythrocytic X 1

          Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin

          Renal Leukemia Erythrocytic X 1

          Lymph Node Mandibular + + + 3

          Leukemia Erythrocytic X 1

          Squamous Cell Carcinoma Metastatic X 1 Skin

          Lymph Node Mesenteric + + 2

          Spleen + + + + + + + + + + + + + + + + + + + + 20

          Leukemia Erythrocytic X 1

          Thymus + + + + + + + + + + + + + + + + + + + M 19

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 14

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 720 NGKG

          0 0 3 4 1

          0 0 3 4 2

          0 0 3 4 3

          0 0 3 4 4

          0 0 3 4 5

          0 0 3 4 6

          0 0 3 4 7

          0 0 3 4 8

          0 0 3 4 9

          0 0 3 5 0

          0 0 3 5 1

          0 0 3 5 2

          0 0 3 5 3

          0 0 3 5 4

          0 0 3 5 5

          0 0 3 5 6

          0 0 3 5 7

          0 0 3 5 8

          0 0 3 5 9

          0 0 3 6 0 TOTALS

          INTEGUMENTARY SYSTEM

          Skin + + + + + + + 7

          Squamous Cell Papilloma X 1

          Squamous Cell Papilloma Multiple X X X 3

          Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

          Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

          Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

          Keratoacanthoma X 1

          Spindle Cell Carcinoma X 1

          Squamous Cell Carcinoma X X X X X 5

          Squamous Cell Carcinoma Multiple X X X X 4

          Squamous Cell Papilloma X 1

          Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

          Skin Soa No Mass + + + + + + + + + + + + + 13

          MUSCULOSKELETAL SYSTEM NONE

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 15

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

          0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 720 NGKG

          NERVOUS SYSTEM NONE

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          RESPIRATORY SYSTEM

          Lung + + + + + + + + + + + + + + + + + + + + 20

          AlveolarBronchiolar Adenoma X 1

          Leukemia Erythrocytic X 1

          Squamous Cell Carcinoma Metastatic X 1 Skin

          SPECIAL SENSES SYSTEM NONE

          URINARY SYSTEM NONE

          SYSTEMIC LESIONS

          Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 16

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

          5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 1520 NGKG

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          ALIMENTARY SYSTEM

          Liver + + + + + + + + + + + + + + + + + + + + 20

          Leukemia Granulocytic X 1

          Stomach Forestomach + + + + + + + + 8

          Squamous Cell Papilloma X X X X 4

          Squamous Cell Papilloma Multiple X X X X 4

          Tooth + + 2

          Odontogenic Tumor X X 2

          CARDIOVASCULAR SYSTEM

          Blood Vessel + 1

          Heart + 1

          ENDOCRINE SYSTEM

          Adrenal Cortex + 1

          Adrenal Medulla + 1

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 17

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

          5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 1520 NGKG

          GENERAL BODY SYSTEM NONE

          GENITAL SYSTEM NONE

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          HEMATOPOIETIC SYSTEM

          Bone Marrow + 1

          Lymph Node + + + + 4

          Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

          Squamous Cell Carcinoma Metastatic X X X 3 Skin

          Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

          Lymph Node Mandibular + + + 3

          Squamous Cell Carcinoma Metastatic X 1 Skin

          Lymph Node Mesenteric + 1

          Spleen + + + + + + + + + + + + + + + + + + + + 20

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 18

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

          5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 1520 NGKG

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          Leukemia Granulocytic X 1

          Thymus + + + M + + + + + + + + + + + M + + + + 18

          INTEGUMENTARY SYSTEM

          Skin + + + + + + + + + + + + + 13

          Squamous Cell Papilloma X X X X X X X 7

          Squamous Cell Papilloma Multiple X X X X X 5

          Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

          Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

          Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

          Spindle Cell Carcinoma X X X 3

          Spindle Cell Carcinoma Multiple X 1

          Squamous Cell Carcinoma X X X X X 5

          Squamous Cell Carcinoma Multiple X X X X X X X 7

          Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

          Skin Soa No Mass + + + + + + + + + + + + 12

          MUSCULOSKELETAL SYSTEM

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 19

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

          5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 1520 NGKG

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          Bone + 1

          NERVOUS SYSTEM

          Brain + 1

          RESPIRATORY SYSTEM

          Lung + + + + + + + + + + + + + + + + + + + + 20

          AlveolarBronchiolar Adenoma X 1

          Leukemia Granulocytic X 1

          Squamous Cell Carcinoma Metastatic X X 2 Skin

          SPECIAL SENSES SYSTEM

          Eye + 1

          URINARY SYSTEM

          Kidney + 1

          Leukemia Granulocytic X 1

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 20

          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

          SpeciesStrain MICETGAC HEMI Lab BAT

          1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

          5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

          ANIMAL ID 1520 NGKG

          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

          SYSTEMIC LESIONS

          Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

          Myelodysplasia X 1

          END OF REPORT

          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

          Control data contained within this report was collected on study 20201-01 Page 21

          • TDMS No 20201 -03 P0413
          • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
          • END OF REPORT

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

            3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 72 NGKG

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            ALIMENTARY SYSTEM

            Liver + + + + + + + + + + + + + + + + + + + + 20

            Mesentery + 1

            Pancreas + 1

            Stomach Forestomach + + 2

            Squamous Cell Papilloma X 1

            Squamous Cell Papilloma Multiple X 1

            Tooth + + + + + + 6

            Odontogenic Tumor X X X X X 5

            Odontogenic Tumor Multiple X 1

            CARDIOVASCULAR SYSTEM NONE

            ENDOCRINE SYSTEM NONE

            GENERAL BODY SYSTEM NONE

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 6

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

            3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 72 NGKG

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            GENITAL SYSTEM

            Ovary + 1

            HEMATOPOIETIC SYSTEM

            Lymph Node Mandibular + 1

            Lymph Node Mesenteric + 1

            Spleen + + + + + + + + + + + + + + + + + + + + 20

            Thymus + + + + + + + + + + + + + + + + + M + + 19

            INTEGUMENTARY SYSTEM

            Skin + + + + 4

            Squamous Cell Papilloma X X X X 4

            Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

            Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

            Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 7

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

            3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 72 NGKG

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            Keratoacanthoma

            Squamous Cell Carcinoma

            Squamous Cell Papilloma

            Squamous Cell Papilloma Multiple

            Skin Soa No Mass

            X 1 X 1

            X X X X X 5 X X X X X X X X X X 10

            + + + + + + + + + + + + + + + + + + + + 20

            MUSCULOSKELETAL SYSTEM NONE

            NERVOUS SYSTEM NONE

            RESPIRATORY SYSTEM

            Lung

            + + + + + + + + + + + + + + + + + + + + 20

            SPECIAL SENSES SYSTEM NONE

            URINARY SYSTEM NONE

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 8

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

            3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 72 NGKG

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            SYSTEMIC LESIONS

            Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 9

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

            3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 242 NGKG

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            ALIMENTARY SYSTEM

            Liver + + + + + + + + + + + + + + + + + + + + 20

            Stomach Forestomach + + 2

            Squamous Cell Papilloma X 1

            Squamous Cell Papilloma Multiple X 1

            Tooth + + + 3

            Odontogenic Tumor X X 2

            CARDIOVASCULAR SYSTEM NONE

            ENDOCRINE SYSTEM

            Pituitary Gland

            + 1

            GENERAL BODY SYSTEM NONE

            GENITAL SYSTEM NONE

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 10

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

            3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 242 NGKG

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            HEMATOPOIETIC SYSTEM

            Spleen + + + + + + + + + + + + + + + + + + + + 20

            Thymus + + + M + + + + + + + + + + + + + + + + 19

            INTEGUMENTARY SYSTEM

            Skin + + + + + + + + 8

            Squamous Cell Papilloma X X X 3

            Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

            Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

            Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

            Spindle Cell Carcinoma X 1

            Squamous Cell Carcinoma X X 2

            Squamous Cell Papilloma X 1

            Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16

            Skin Soa No Mass + + + + + + + + + + + + + + + + + 17

            MUSCULOSKELETAL SYSTEM

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 11

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

            3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 242 NGKG

            NONE

            NERVOUS SYSTEM NONE

            RESPIRATORY SYSTEM

            Lung

            + + + + + + + + + + + + + + + + + + + + 20

            SPECIAL SENSES SYSTEM NONE

            URINARY SYSTEM NONE

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            SYSTEMIC LESIONS

            Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 12

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

            0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 720 NGKG

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            ALIMENTARY SYSTEM

            Liver + + + + + + + + + + + + + + + + + + + + 20

            Leukemia Erythrocytic X 1

            Stomach Forestomach + + + + + 5

            Squamous Cell Papilloma X X X X X 5

            Tooth + 1

            CARDIOVASCULAR SYSTEM NONE

            ENDOCRINE SYSTEM

            Pituitary Gland

            Leukemia Erythrocytic

            + 1 X 1

            GENERAL BODY SYSTEM NONE

            GENITAL SYSTEM NONE

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 13

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

            0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 720 NGKG

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            HEMATOPOIETIC SYSTEM

            Lymph Node + + + + + + + + 8

            Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

            Squamous Cell Carcinoma Metastatic X 1 Lymph Node

            Squamous Cell Carcinoma Metastatic X X X 3 Skin

            Lumbar Leukemia Erythrocytic X 1

            Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin

            Renal Leukemia Erythrocytic X 1

            Lymph Node Mandibular + + + 3

            Leukemia Erythrocytic X 1

            Squamous Cell Carcinoma Metastatic X 1 Skin

            Lymph Node Mesenteric + + 2

            Spleen + + + + + + + + + + + + + + + + + + + + 20

            Leukemia Erythrocytic X 1

            Thymus + + + + + + + + + + + + + + + + + + + M 19

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 14

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 720 NGKG

            0 0 3 4 1

            0 0 3 4 2

            0 0 3 4 3

            0 0 3 4 4

            0 0 3 4 5

            0 0 3 4 6

            0 0 3 4 7

            0 0 3 4 8

            0 0 3 4 9

            0 0 3 5 0

            0 0 3 5 1

            0 0 3 5 2

            0 0 3 5 3

            0 0 3 5 4

            0 0 3 5 5

            0 0 3 5 6

            0 0 3 5 7

            0 0 3 5 8

            0 0 3 5 9

            0 0 3 6 0 TOTALS

            INTEGUMENTARY SYSTEM

            Skin + + + + + + + 7

            Squamous Cell Papilloma X 1

            Squamous Cell Papilloma Multiple X X X 3

            Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

            Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

            Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

            Keratoacanthoma X 1

            Spindle Cell Carcinoma X 1

            Squamous Cell Carcinoma X X X X X 5

            Squamous Cell Carcinoma Multiple X X X X 4

            Squamous Cell Papilloma X 1

            Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

            Skin Soa No Mass + + + + + + + + + + + + + 13

            MUSCULOSKELETAL SYSTEM NONE

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 15

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

            0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 720 NGKG

            NERVOUS SYSTEM NONE

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            RESPIRATORY SYSTEM

            Lung + + + + + + + + + + + + + + + + + + + + 20

            AlveolarBronchiolar Adenoma X 1

            Leukemia Erythrocytic X 1

            Squamous Cell Carcinoma Metastatic X 1 Skin

            SPECIAL SENSES SYSTEM NONE

            URINARY SYSTEM NONE

            SYSTEMIC LESIONS

            Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 16

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

            5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 1520 NGKG

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            ALIMENTARY SYSTEM

            Liver + + + + + + + + + + + + + + + + + + + + 20

            Leukemia Granulocytic X 1

            Stomach Forestomach + + + + + + + + 8

            Squamous Cell Papilloma X X X X 4

            Squamous Cell Papilloma Multiple X X X X 4

            Tooth + + 2

            Odontogenic Tumor X X 2

            CARDIOVASCULAR SYSTEM

            Blood Vessel + 1

            Heart + 1

            ENDOCRINE SYSTEM

            Adrenal Cortex + 1

            Adrenal Medulla + 1

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 17

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

            5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 1520 NGKG

            GENERAL BODY SYSTEM NONE

            GENITAL SYSTEM NONE

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            HEMATOPOIETIC SYSTEM

            Bone Marrow + 1

            Lymph Node + + + + 4

            Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

            Squamous Cell Carcinoma Metastatic X X X 3 Skin

            Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

            Lymph Node Mandibular + + + 3

            Squamous Cell Carcinoma Metastatic X 1 Skin

            Lymph Node Mesenteric + 1

            Spleen + + + + + + + + + + + + + + + + + + + + 20

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 18

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

            5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 1520 NGKG

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            Leukemia Granulocytic X 1

            Thymus + + + M + + + + + + + + + + + M + + + + 18

            INTEGUMENTARY SYSTEM

            Skin + + + + + + + + + + + + + 13

            Squamous Cell Papilloma X X X X X X X 7

            Squamous Cell Papilloma Multiple X X X X X 5

            Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

            Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

            Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

            Spindle Cell Carcinoma X X X 3

            Spindle Cell Carcinoma Multiple X 1

            Squamous Cell Carcinoma X X X X X 5

            Squamous Cell Carcinoma Multiple X X X X X X X 7

            Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

            Skin Soa No Mass + + + + + + + + + + + + 12

            MUSCULOSKELETAL SYSTEM

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 19

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

            5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 1520 NGKG

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            Bone + 1

            NERVOUS SYSTEM

            Brain + 1

            RESPIRATORY SYSTEM

            Lung + + + + + + + + + + + + + + + + + + + + 20

            AlveolarBronchiolar Adenoma X 1

            Leukemia Granulocytic X 1

            Squamous Cell Carcinoma Metastatic X X 2 Skin

            SPECIAL SENSES SYSTEM

            Eye + 1

            URINARY SYSTEM

            Kidney + 1

            Leukemia Granulocytic X 1

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 20

            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

            SpeciesStrain MICETGAC HEMI Lab BAT

            1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

            5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

            ANIMAL ID 1520 NGKG

            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

            SYSTEMIC LESIONS

            Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

            Myelodysplasia X 1

            END OF REPORT

            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

            Control data contained within this report was collected on study 20201-01 Page 21

            • TDMS No 20201 -03 P0413
            • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
            • END OF REPORT

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

              3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 72 NGKG

              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

              GENITAL SYSTEM

              Ovary + 1

              HEMATOPOIETIC SYSTEM

              Lymph Node Mandibular + 1

              Lymph Node Mesenteric + 1

              Spleen + + + + + + + + + + + + + + + + + + + + 20

              Thymus + + + + + + + + + + + + + + + + + M + + 19

              INTEGUMENTARY SYSTEM

              Skin + + + + 4

              Squamous Cell Papilloma X X X X 4

              Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

              Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

              Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 7

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

              3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 72 NGKG

              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

              Keratoacanthoma

              Squamous Cell Carcinoma

              Squamous Cell Papilloma

              Squamous Cell Papilloma Multiple

              Skin Soa No Mass

              X 1 X 1

              X X X X X 5 X X X X X X X X X X 10

              + + + + + + + + + + + + + + + + + + + + 20

              MUSCULOSKELETAL SYSTEM NONE

              NERVOUS SYSTEM NONE

              RESPIRATORY SYSTEM

              Lung

              + + + + + + + + + + + + + + + + + + + + 20

              SPECIAL SENSES SYSTEM NONE

              URINARY SYSTEM NONE

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 8

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

              3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 72 NGKG

              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

              SYSTEMIC LESIONS

              Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 9

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

              3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 242 NGKG

              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

              ALIMENTARY SYSTEM

              Liver + + + + + + + + + + + + + + + + + + + + 20

              Stomach Forestomach + + 2

              Squamous Cell Papilloma X 1

              Squamous Cell Papilloma Multiple X 1

              Tooth + + + 3

              Odontogenic Tumor X X 2

              CARDIOVASCULAR SYSTEM NONE

              ENDOCRINE SYSTEM

              Pituitary Gland

              + 1

              GENERAL BODY SYSTEM NONE

              GENITAL SYSTEM NONE

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 10

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

              3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 242 NGKG

              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

              HEMATOPOIETIC SYSTEM

              Spleen + + + + + + + + + + + + + + + + + + + + 20

              Thymus + + + M + + + + + + + + + + + + + + + + 19

              INTEGUMENTARY SYSTEM

              Skin + + + + + + + + 8

              Squamous Cell Papilloma X X X 3

              Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

              Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

              Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

              Spindle Cell Carcinoma X 1

              Squamous Cell Carcinoma X X 2

              Squamous Cell Papilloma X 1

              Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16

              Skin Soa No Mass + + + + + + + + + + + + + + + + + 17

              MUSCULOSKELETAL SYSTEM

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 11

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

              3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 242 NGKG

              NONE

              NERVOUS SYSTEM NONE

              RESPIRATORY SYSTEM

              Lung

              + + + + + + + + + + + + + + + + + + + + 20

              SPECIAL SENSES SYSTEM NONE

              URINARY SYSTEM NONE

              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

              SYSTEMIC LESIONS

              Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 12

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

              0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 720 NGKG

              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

              ALIMENTARY SYSTEM

              Liver + + + + + + + + + + + + + + + + + + + + 20

              Leukemia Erythrocytic X 1

              Stomach Forestomach + + + + + 5

              Squamous Cell Papilloma X X X X X 5

              Tooth + 1

              CARDIOVASCULAR SYSTEM NONE

              ENDOCRINE SYSTEM

              Pituitary Gland

              Leukemia Erythrocytic

              + 1 X 1

              GENERAL BODY SYSTEM NONE

              GENITAL SYSTEM NONE

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 13

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

              0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 720 NGKG

              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

              HEMATOPOIETIC SYSTEM

              Lymph Node + + + + + + + + 8

              Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

              Squamous Cell Carcinoma Metastatic X 1 Lymph Node

              Squamous Cell Carcinoma Metastatic X X X 3 Skin

              Lumbar Leukemia Erythrocytic X 1

              Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin

              Renal Leukemia Erythrocytic X 1

              Lymph Node Mandibular + + + 3

              Leukemia Erythrocytic X 1

              Squamous Cell Carcinoma Metastatic X 1 Skin

              Lymph Node Mesenteric + + 2

              Spleen + + + + + + + + + + + + + + + + + + + + 20

              Leukemia Erythrocytic X 1

              Thymus + + + + + + + + + + + + + + + + + + + M 19

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 14

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 720 NGKG

              0 0 3 4 1

              0 0 3 4 2

              0 0 3 4 3

              0 0 3 4 4

              0 0 3 4 5

              0 0 3 4 6

              0 0 3 4 7

              0 0 3 4 8

              0 0 3 4 9

              0 0 3 5 0

              0 0 3 5 1

              0 0 3 5 2

              0 0 3 5 3

              0 0 3 5 4

              0 0 3 5 5

              0 0 3 5 6

              0 0 3 5 7

              0 0 3 5 8

              0 0 3 5 9

              0 0 3 6 0 TOTALS

              INTEGUMENTARY SYSTEM

              Skin + + + + + + + 7

              Squamous Cell Papilloma X 1

              Squamous Cell Papilloma Multiple X X X 3

              Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

              Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

              Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

              Keratoacanthoma X 1

              Spindle Cell Carcinoma X 1

              Squamous Cell Carcinoma X X X X X 5

              Squamous Cell Carcinoma Multiple X X X X 4

              Squamous Cell Papilloma X 1

              Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

              Skin Soa No Mass + + + + + + + + + + + + + 13

              MUSCULOSKELETAL SYSTEM NONE

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 15

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

              0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 720 NGKG

              NERVOUS SYSTEM NONE

              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

              RESPIRATORY SYSTEM

              Lung + + + + + + + + + + + + + + + + + + + + 20

              AlveolarBronchiolar Adenoma X 1

              Leukemia Erythrocytic X 1

              Squamous Cell Carcinoma Metastatic X 1 Skin

              SPECIAL SENSES SYSTEM NONE

              URINARY SYSTEM NONE

              SYSTEMIC LESIONS

              Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 16

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

              5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 1520 NGKG

              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

              ALIMENTARY SYSTEM

              Liver + + + + + + + + + + + + + + + + + + + + 20

              Leukemia Granulocytic X 1

              Stomach Forestomach + + + + + + + + 8

              Squamous Cell Papilloma X X X X 4

              Squamous Cell Papilloma Multiple X X X X 4

              Tooth + + 2

              Odontogenic Tumor X X 2

              CARDIOVASCULAR SYSTEM

              Blood Vessel + 1

              Heart + 1

              ENDOCRINE SYSTEM

              Adrenal Cortex + 1

              Adrenal Medulla + 1

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 17

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

              5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 1520 NGKG

              GENERAL BODY SYSTEM NONE

              GENITAL SYSTEM NONE

              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

              HEMATOPOIETIC SYSTEM

              Bone Marrow + 1

              Lymph Node + + + + 4

              Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

              Squamous Cell Carcinoma Metastatic X X X 3 Skin

              Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

              Lymph Node Mandibular + + + 3

              Squamous Cell Carcinoma Metastatic X 1 Skin

              Lymph Node Mesenteric + 1

              Spleen + + + + + + + + + + + + + + + + + + + + 20

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 18

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

              5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 1520 NGKG

              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

              Leukemia Granulocytic X 1

              Thymus + + + M + + + + + + + + + + + M + + + + 18

              INTEGUMENTARY SYSTEM

              Skin + + + + + + + + + + + + + 13

              Squamous Cell Papilloma X X X X X X X 7

              Squamous Cell Papilloma Multiple X X X X X 5

              Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

              Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

              Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

              Spindle Cell Carcinoma X X X 3

              Spindle Cell Carcinoma Multiple X 1

              Squamous Cell Carcinoma X X X X X 5

              Squamous Cell Carcinoma Multiple X X X X X X X 7

              Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

              Skin Soa No Mass + + + + + + + + + + + + 12

              MUSCULOSKELETAL SYSTEM

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 19

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

              5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 1520 NGKG

              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

              Bone + 1

              NERVOUS SYSTEM

              Brain + 1

              RESPIRATORY SYSTEM

              Lung + + + + + + + + + + + + + + + + + + + + 20

              AlveolarBronchiolar Adenoma X 1

              Leukemia Granulocytic X 1

              Squamous Cell Carcinoma Metastatic X X 2 Skin

              SPECIAL SENSES SYSTEM

              Eye + 1

              URINARY SYSTEM

              Kidney + 1

              Leukemia Granulocytic X 1

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 20

              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

              SpeciesStrain MICETGAC HEMI Lab BAT

              1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

              5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

              ANIMAL ID 1520 NGKG

              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

              SYSTEMIC LESIONS

              Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

              Myelodysplasia X 1

              END OF REPORT

              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

              Control data contained within this report was collected on study 20201-01 Page 21

              • TDMS No 20201 -03 P0413
              • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
              • END OF REPORT

                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                SpeciesStrain MICETGAC HEMI Lab BAT

                1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

                3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                ANIMAL ID 72 NGKG

                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                Keratoacanthoma

                Squamous Cell Carcinoma

                Squamous Cell Papilloma

                Squamous Cell Papilloma Multiple

                Skin Soa No Mass

                X 1 X 1

                X X X X X 5 X X X X X X X X X X 10

                + + + + + + + + + + + + + + + + + + + + 20

                MUSCULOSKELETAL SYSTEM NONE

                NERVOUS SYSTEM NONE

                RESPIRATORY SYSTEM

                Lung

                + + + + + + + + + + + + + + + + + + + + 20

                SPECIAL SENSES SYSTEM NONE

                URINARY SYSTEM NONE

                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                Control data contained within this report was collected on study 20201-01 Page 8

                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                SpeciesStrain MICETGAC HEMI Lab BAT

                1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

                3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                ANIMAL ID 72 NGKG

                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                SYSTEMIC LESIONS

                Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                Control data contained within this report was collected on study 20201-01 Page 9

                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                SpeciesStrain MICETGAC HEMI Lab BAT

                1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

                3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                ANIMAL ID 242 NGKG

                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                ALIMENTARY SYSTEM

                Liver + + + + + + + + + + + + + + + + + + + + 20

                Stomach Forestomach + + 2

                Squamous Cell Papilloma X 1

                Squamous Cell Papilloma Multiple X 1

                Tooth + + + 3

                Odontogenic Tumor X X 2

                CARDIOVASCULAR SYSTEM NONE

                ENDOCRINE SYSTEM

                Pituitary Gland

                + 1

                GENERAL BODY SYSTEM NONE

                GENITAL SYSTEM NONE

                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                Control data contained within this report was collected on study 20201-01 Page 10

                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                SpeciesStrain MICETGAC HEMI Lab BAT

                1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

                3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                ANIMAL ID 242 NGKG

                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                HEMATOPOIETIC SYSTEM

                Spleen + + + + + + + + + + + + + + + + + + + + 20

                Thymus + + + M + + + + + + + + + + + + + + + + 19

                INTEGUMENTARY SYSTEM

                Skin + + + + + + + + 8

                Squamous Cell Papilloma X X X 3

                Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                Spindle Cell Carcinoma X 1

                Squamous Cell Carcinoma X X 2

                Squamous Cell Papilloma X 1

                Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16

                Skin Soa No Mass + + + + + + + + + + + + + + + + + 17

                MUSCULOSKELETAL SYSTEM

                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                Control data contained within this report was collected on study 20201-01 Page 11

                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                SpeciesStrain MICETGAC HEMI Lab BAT

                1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

                3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                ANIMAL ID 242 NGKG

                NONE

                NERVOUS SYSTEM NONE

                RESPIRATORY SYSTEM

                Lung

                + + + + + + + + + + + + + + + + + + + + 20

                SPECIAL SENSES SYSTEM NONE

                URINARY SYSTEM NONE

                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                SYSTEMIC LESIONS

                Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                Control data contained within this report was collected on study 20201-01 Page 12

                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                SpeciesStrain MICETGAC HEMI Lab BAT

                0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                ANIMAL ID 720 NGKG

                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                ALIMENTARY SYSTEM

                Liver + + + + + + + + + + + + + + + + + + + + 20

                Leukemia Erythrocytic X 1

                Stomach Forestomach + + + + + 5

                Squamous Cell Papilloma X X X X X 5

                Tooth + 1

                CARDIOVASCULAR SYSTEM NONE

                ENDOCRINE SYSTEM

                Pituitary Gland

                Leukemia Erythrocytic

                + 1 X 1

                GENERAL BODY SYSTEM NONE

                GENITAL SYSTEM NONE

                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                Control data contained within this report was collected on study 20201-01 Page 13

                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                SpeciesStrain MICETGAC HEMI Lab BAT

                0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                ANIMAL ID 720 NGKG

                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                HEMATOPOIETIC SYSTEM

                Lymph Node + + + + + + + + 8

                Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                Squamous Cell Carcinoma Metastatic X 1 Lymph Node

                Squamous Cell Carcinoma Metastatic X X X 3 Skin

                Lumbar Leukemia Erythrocytic X 1

                Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin

                Renal Leukemia Erythrocytic X 1

                Lymph Node Mandibular + + + 3

                Leukemia Erythrocytic X 1

                Squamous Cell Carcinoma Metastatic X 1 Skin

                Lymph Node Mesenteric + + 2

                Spleen + + + + + + + + + + + + + + + + + + + + 20

                Leukemia Erythrocytic X 1

                Thymus + + + + + + + + + + + + + + + + + + + M 19

                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                Control data contained within this report was collected on study 20201-01 Page 14

                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                SpeciesStrain MICETGAC HEMI Lab BAT

                0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                ANIMAL ID 720 NGKG

                0 0 3 4 1

                0 0 3 4 2

                0 0 3 4 3

                0 0 3 4 4

                0 0 3 4 5

                0 0 3 4 6

                0 0 3 4 7

                0 0 3 4 8

                0 0 3 4 9

                0 0 3 5 0

                0 0 3 5 1

                0 0 3 5 2

                0 0 3 5 3

                0 0 3 5 4

                0 0 3 5 5

                0 0 3 5 6

                0 0 3 5 7

                0 0 3 5 8

                0 0 3 5 9

                0 0 3 6 0 TOTALS

                INTEGUMENTARY SYSTEM

                Skin + + + + + + + 7

                Squamous Cell Papilloma X 1

                Squamous Cell Papilloma Multiple X X X 3

                Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                Keratoacanthoma X 1

                Spindle Cell Carcinoma X 1

                Squamous Cell Carcinoma X X X X X 5

                Squamous Cell Carcinoma Multiple X X X X 4

                Squamous Cell Papilloma X 1

                Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

                Skin Soa No Mass + + + + + + + + + + + + + 13

                MUSCULOSKELETAL SYSTEM NONE

                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                Control data contained within this report was collected on study 20201-01 Page 15

                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                SpeciesStrain MICETGAC HEMI Lab BAT

                0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                ANIMAL ID 720 NGKG

                NERVOUS SYSTEM NONE

                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                RESPIRATORY SYSTEM

                Lung + + + + + + + + + + + + + + + + + + + + 20

                AlveolarBronchiolar Adenoma X 1

                Leukemia Erythrocytic X 1

                Squamous Cell Carcinoma Metastatic X 1 Skin

                SPECIAL SENSES SYSTEM NONE

                URINARY SYSTEM NONE

                SYSTEMIC LESIONS

                Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                Control data contained within this report was collected on study 20201-01 Page 16

                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                SpeciesStrain MICETGAC HEMI Lab BAT

                1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                ANIMAL ID 1520 NGKG

                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                ALIMENTARY SYSTEM

                Liver + + + + + + + + + + + + + + + + + + + + 20

                Leukemia Granulocytic X 1

                Stomach Forestomach + + + + + + + + 8

                Squamous Cell Papilloma X X X X 4

                Squamous Cell Papilloma Multiple X X X X 4

                Tooth + + 2

                Odontogenic Tumor X X 2

                CARDIOVASCULAR SYSTEM

                Blood Vessel + 1

                Heart + 1

                ENDOCRINE SYSTEM

                Adrenal Cortex + 1

                Adrenal Medulla + 1

                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                Control data contained within this report was collected on study 20201-01 Page 17

                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                SpeciesStrain MICETGAC HEMI Lab BAT

                1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                ANIMAL ID 1520 NGKG

                GENERAL BODY SYSTEM NONE

                GENITAL SYSTEM NONE

                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                HEMATOPOIETIC SYSTEM

                Bone Marrow + 1

                Lymph Node + + + + 4

                Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                Squamous Cell Carcinoma Metastatic X X X 3 Skin

                Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

                Lymph Node Mandibular + + + 3

                Squamous Cell Carcinoma Metastatic X 1 Skin

                Lymph Node Mesenteric + 1

                Spleen + + + + + + + + + + + + + + + + + + + + 20

                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                Control data contained within this report was collected on study 20201-01 Page 18

                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                SpeciesStrain MICETGAC HEMI Lab BAT

                1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                ANIMAL ID 1520 NGKG

                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                Leukemia Granulocytic X 1

                Thymus + + + M + + + + + + + + + + + M + + + + 18

                INTEGUMENTARY SYSTEM

                Skin + + + + + + + + + + + + + 13

                Squamous Cell Papilloma X X X X X X X 7

                Squamous Cell Papilloma Multiple X X X X X 5

                Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                Spindle Cell Carcinoma X X X 3

                Spindle Cell Carcinoma Multiple X 1

                Squamous Cell Carcinoma X X X X X 5

                Squamous Cell Carcinoma Multiple X X X X X X X 7

                Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

                Skin Soa No Mass + + + + + + + + + + + + 12

                MUSCULOSKELETAL SYSTEM

                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                Control data contained within this report was collected on study 20201-01 Page 19

                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                SpeciesStrain MICETGAC HEMI Lab BAT

                1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                ANIMAL ID 1520 NGKG

                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                Bone + 1

                NERVOUS SYSTEM

                Brain + 1

                RESPIRATORY SYSTEM

                Lung + + + + + + + + + + + + + + + + + + + + 20

                AlveolarBronchiolar Adenoma X 1

                Leukemia Granulocytic X 1

                Squamous Cell Carcinoma Metastatic X X 2 Skin

                SPECIAL SENSES SYSTEM

                Eye + 1

                URINARY SYSTEM

                Kidney + 1

                Leukemia Granulocytic X 1

                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                Control data contained within this report was collected on study 20201-01 Page 20

                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                SpeciesStrain MICETGAC HEMI Lab BAT

                1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                ANIMAL ID 1520 NGKG

                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                SYSTEMIC LESIONS

                Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

                Myelodysplasia X 1

                END OF REPORT

                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                Control data contained within this report was collected on study 20201-01 Page 21

                • TDMS No 20201 -03 P0413
                • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
                • END OF REPORT

                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                  SpeciesStrain MICETGAC HEMI Lab BAT

                  1 1 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 DAY ON TEST 3 8 7 8 8 8 2 5 9 8 8 5 8 8 8 8 8 9 8 8

                  3 5 8 3 6 5 7 4 7 3 5 7 6 5 5 7 3 4 3 4

                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                  ANIMAL ID 72 NGKG

                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 2 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                  SYSTEMIC LESIONS

                  Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                  Control data contained within this report was collected on study 20201-01 Page 9

                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                  SpeciesStrain MICETGAC HEMI Lab BAT

                  1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

                  3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                  ANIMAL ID 242 NGKG

                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                  ALIMENTARY SYSTEM

                  Liver + + + + + + + + + + + + + + + + + + + + 20

                  Stomach Forestomach + + 2

                  Squamous Cell Papilloma X 1

                  Squamous Cell Papilloma Multiple X 1

                  Tooth + + + 3

                  Odontogenic Tumor X X 2

                  CARDIOVASCULAR SYSTEM NONE

                  ENDOCRINE SYSTEM

                  Pituitary Gland

                  + 1

                  GENERAL BODY SYSTEM NONE

                  GENITAL SYSTEM NONE

                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                  Control data contained within this report was collected on study 20201-01 Page 10

                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                  SpeciesStrain MICETGAC HEMI Lab BAT

                  1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

                  3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                  ANIMAL ID 242 NGKG

                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                  HEMATOPOIETIC SYSTEM

                  Spleen + + + + + + + + + + + + + + + + + + + + 20

                  Thymus + + + M + + + + + + + + + + + + + + + + 19

                  INTEGUMENTARY SYSTEM

                  Skin + + + + + + + + 8

                  Squamous Cell Papilloma X X X 3

                  Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                  Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                  Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                  Spindle Cell Carcinoma X 1

                  Squamous Cell Carcinoma X X 2

                  Squamous Cell Papilloma X 1

                  Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16

                  Skin Soa No Mass + + + + + + + + + + + + + + + + + 17

                  MUSCULOSKELETAL SYSTEM

                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                  Control data contained within this report was collected on study 20201-01 Page 11

                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                  SpeciesStrain MICETGAC HEMI Lab BAT

                  1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

                  3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                  ANIMAL ID 242 NGKG

                  NONE

                  NERVOUS SYSTEM NONE

                  RESPIRATORY SYSTEM

                  Lung

                  + + + + + + + + + + + + + + + + + + + + 20

                  SPECIAL SENSES SYSTEM NONE

                  URINARY SYSTEM NONE

                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                  SYSTEMIC LESIONS

                  Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                  Control data contained within this report was collected on study 20201-01 Page 12

                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                  SpeciesStrain MICETGAC HEMI Lab BAT

                  0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                  0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                  ANIMAL ID 720 NGKG

                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                  ALIMENTARY SYSTEM

                  Liver + + + + + + + + + + + + + + + + + + + + 20

                  Leukemia Erythrocytic X 1

                  Stomach Forestomach + + + + + 5

                  Squamous Cell Papilloma X X X X X 5

                  Tooth + 1

                  CARDIOVASCULAR SYSTEM NONE

                  ENDOCRINE SYSTEM

                  Pituitary Gland

                  Leukemia Erythrocytic

                  + 1 X 1

                  GENERAL BODY SYSTEM NONE

                  GENITAL SYSTEM NONE

                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                  Control data contained within this report was collected on study 20201-01 Page 13

                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                  SpeciesStrain MICETGAC HEMI Lab BAT

                  0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                  0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                  ANIMAL ID 720 NGKG

                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                  HEMATOPOIETIC SYSTEM

                  Lymph Node + + + + + + + + 8

                  Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                  Squamous Cell Carcinoma Metastatic X 1 Lymph Node

                  Squamous Cell Carcinoma Metastatic X X X 3 Skin

                  Lumbar Leukemia Erythrocytic X 1

                  Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin

                  Renal Leukemia Erythrocytic X 1

                  Lymph Node Mandibular + + + 3

                  Leukemia Erythrocytic X 1

                  Squamous Cell Carcinoma Metastatic X 1 Skin

                  Lymph Node Mesenteric + + 2

                  Spleen + + + + + + + + + + + + + + + + + + + + 20

                  Leukemia Erythrocytic X 1

                  Thymus + + + + + + + + + + + + + + + + + + + M 19

                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                  Control data contained within this report was collected on study 20201-01 Page 14

                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                  SpeciesStrain MICETGAC HEMI Lab BAT

                  0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                  ANIMAL ID 720 NGKG

                  0 0 3 4 1

                  0 0 3 4 2

                  0 0 3 4 3

                  0 0 3 4 4

                  0 0 3 4 5

                  0 0 3 4 6

                  0 0 3 4 7

                  0 0 3 4 8

                  0 0 3 4 9

                  0 0 3 5 0

                  0 0 3 5 1

                  0 0 3 5 2

                  0 0 3 5 3

                  0 0 3 5 4

                  0 0 3 5 5

                  0 0 3 5 6

                  0 0 3 5 7

                  0 0 3 5 8

                  0 0 3 5 9

                  0 0 3 6 0 TOTALS

                  INTEGUMENTARY SYSTEM

                  Skin + + + + + + + 7

                  Squamous Cell Papilloma X 1

                  Squamous Cell Papilloma Multiple X X X 3

                  Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                  Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                  Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                  Keratoacanthoma X 1

                  Spindle Cell Carcinoma X 1

                  Squamous Cell Carcinoma X X X X X 5

                  Squamous Cell Carcinoma Multiple X X X X 4

                  Squamous Cell Papilloma X 1

                  Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

                  Skin Soa No Mass + + + + + + + + + + + + + 13

                  MUSCULOSKELETAL SYSTEM NONE

                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                  Control data contained within this report was collected on study 20201-01 Page 15

                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                  SpeciesStrain MICETGAC HEMI Lab BAT

                  0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                  0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                  ANIMAL ID 720 NGKG

                  NERVOUS SYSTEM NONE

                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                  RESPIRATORY SYSTEM

                  Lung + + + + + + + + + + + + + + + + + + + + 20

                  AlveolarBronchiolar Adenoma X 1

                  Leukemia Erythrocytic X 1

                  Squamous Cell Carcinoma Metastatic X 1 Skin

                  SPECIAL SENSES SYSTEM NONE

                  URINARY SYSTEM NONE

                  SYSTEMIC LESIONS

                  Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                  Control data contained within this report was collected on study 20201-01 Page 16

                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                  SpeciesStrain MICETGAC HEMI Lab BAT

                  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                  5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                  ANIMAL ID 1520 NGKG

                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                  ALIMENTARY SYSTEM

                  Liver + + + + + + + + + + + + + + + + + + + + 20

                  Leukemia Granulocytic X 1

                  Stomach Forestomach + + + + + + + + 8

                  Squamous Cell Papilloma X X X X 4

                  Squamous Cell Papilloma Multiple X X X X 4

                  Tooth + + 2

                  Odontogenic Tumor X X 2

                  CARDIOVASCULAR SYSTEM

                  Blood Vessel + 1

                  Heart + 1

                  ENDOCRINE SYSTEM

                  Adrenal Cortex + 1

                  Adrenal Medulla + 1

                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                  Control data contained within this report was collected on study 20201-01 Page 17

                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                  SpeciesStrain MICETGAC HEMI Lab BAT

                  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                  5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                  ANIMAL ID 1520 NGKG

                  GENERAL BODY SYSTEM NONE

                  GENITAL SYSTEM NONE

                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                  HEMATOPOIETIC SYSTEM

                  Bone Marrow + 1

                  Lymph Node + + + + 4

                  Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                  Squamous Cell Carcinoma Metastatic X X X 3 Skin

                  Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

                  Lymph Node Mandibular + + + 3

                  Squamous Cell Carcinoma Metastatic X 1 Skin

                  Lymph Node Mesenteric + 1

                  Spleen + + + + + + + + + + + + + + + + + + + + 20

                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                  Control data contained within this report was collected on study 20201-01 Page 18

                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                  SpeciesStrain MICETGAC HEMI Lab BAT

                  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                  5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                  ANIMAL ID 1520 NGKG

                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                  Leukemia Granulocytic X 1

                  Thymus + + + M + + + + + + + + + + + M + + + + 18

                  INTEGUMENTARY SYSTEM

                  Skin + + + + + + + + + + + + + 13

                  Squamous Cell Papilloma X X X X X X X 7

                  Squamous Cell Papilloma Multiple X X X X X 5

                  Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                  Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                  Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                  Spindle Cell Carcinoma X X X 3

                  Spindle Cell Carcinoma Multiple X 1

                  Squamous Cell Carcinoma X X X X X 5

                  Squamous Cell Carcinoma Multiple X X X X X X X 7

                  Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

                  Skin Soa No Mass + + + + + + + + + + + + 12

                  MUSCULOSKELETAL SYSTEM

                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                  Control data contained within this report was collected on study 20201-01 Page 19

                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                  SpeciesStrain MICETGAC HEMI Lab BAT

                  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                  5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                  ANIMAL ID 1520 NGKG

                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                  Bone + 1

                  NERVOUS SYSTEM

                  Brain + 1

                  RESPIRATORY SYSTEM

                  Lung + + + + + + + + + + + + + + + + + + + + 20

                  AlveolarBronchiolar Adenoma X 1

                  Leukemia Granulocytic X 1

                  Squamous Cell Carcinoma Metastatic X X 2 Skin

                  SPECIAL SENSES SYSTEM

                  Eye + 1

                  URINARY SYSTEM

                  Kidney + 1

                  Leukemia Granulocytic X 1

                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                  Control data contained within this report was collected on study 20201-01 Page 20

                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                  SpeciesStrain MICETGAC HEMI Lab BAT

                  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                  5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                  ANIMAL ID 1520 NGKG

                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                  SYSTEMIC LESIONS

                  Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

                  Myelodysplasia X 1

                  END OF REPORT

                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                  Control data contained within this report was collected on study 20201-01 Page 21

                  • TDMS No 20201 -03 P0413
                  • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
                  • END OF REPORT

                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                    SpeciesStrain MICETGAC HEMI Lab BAT

                    1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

                    3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                    ANIMAL ID 242 NGKG

                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                    ALIMENTARY SYSTEM

                    Liver + + + + + + + + + + + + + + + + + + + + 20

                    Stomach Forestomach + + 2

                    Squamous Cell Papilloma X 1

                    Squamous Cell Papilloma Multiple X 1

                    Tooth + + + 3

                    Odontogenic Tumor X X 2

                    CARDIOVASCULAR SYSTEM NONE

                    ENDOCRINE SYSTEM

                    Pituitary Gland

                    + 1

                    GENERAL BODY SYSTEM NONE

                    GENITAL SYSTEM NONE

                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                    Control data contained within this report was collected on study 20201-01 Page 10

                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                    SpeciesStrain MICETGAC HEMI Lab BAT

                    1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

                    3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                    ANIMAL ID 242 NGKG

                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                    HEMATOPOIETIC SYSTEM

                    Spleen + + + + + + + + + + + + + + + + + + + + 20

                    Thymus + + + M + + + + + + + + + + + + + + + + 19

                    INTEGUMENTARY SYSTEM

                    Skin + + + + + + + + 8

                    Squamous Cell Papilloma X X X 3

                    Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                    Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                    Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                    Spindle Cell Carcinoma X 1

                    Squamous Cell Carcinoma X X 2

                    Squamous Cell Papilloma X 1

                    Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16

                    Skin Soa No Mass + + + + + + + + + + + + + + + + + 17

                    MUSCULOSKELETAL SYSTEM

                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                    Control data contained within this report was collected on study 20201-01 Page 11

                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                    SpeciesStrain MICETGAC HEMI Lab BAT

                    1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

                    3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                    ANIMAL ID 242 NGKG

                    NONE

                    NERVOUS SYSTEM NONE

                    RESPIRATORY SYSTEM

                    Lung

                    + + + + + + + + + + + + + + + + + + + + 20

                    SPECIAL SENSES SYSTEM NONE

                    URINARY SYSTEM NONE

                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                    SYSTEMIC LESIONS

                    Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                    Control data contained within this report was collected on study 20201-01 Page 12

                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                    SpeciesStrain MICETGAC HEMI Lab BAT

                    0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                    0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                    ANIMAL ID 720 NGKG

                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                    ALIMENTARY SYSTEM

                    Liver + + + + + + + + + + + + + + + + + + + + 20

                    Leukemia Erythrocytic X 1

                    Stomach Forestomach + + + + + 5

                    Squamous Cell Papilloma X X X X X 5

                    Tooth + 1

                    CARDIOVASCULAR SYSTEM NONE

                    ENDOCRINE SYSTEM

                    Pituitary Gland

                    Leukemia Erythrocytic

                    + 1 X 1

                    GENERAL BODY SYSTEM NONE

                    GENITAL SYSTEM NONE

                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                    Control data contained within this report was collected on study 20201-01 Page 13

                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                    SpeciesStrain MICETGAC HEMI Lab BAT

                    0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                    0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                    ANIMAL ID 720 NGKG

                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                    HEMATOPOIETIC SYSTEM

                    Lymph Node + + + + + + + + 8

                    Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                    Squamous Cell Carcinoma Metastatic X 1 Lymph Node

                    Squamous Cell Carcinoma Metastatic X X X 3 Skin

                    Lumbar Leukemia Erythrocytic X 1

                    Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin

                    Renal Leukemia Erythrocytic X 1

                    Lymph Node Mandibular + + + 3

                    Leukemia Erythrocytic X 1

                    Squamous Cell Carcinoma Metastatic X 1 Skin

                    Lymph Node Mesenteric + + 2

                    Spleen + + + + + + + + + + + + + + + + + + + + 20

                    Leukemia Erythrocytic X 1

                    Thymus + + + + + + + + + + + + + + + + + + + M 19

                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                    Control data contained within this report was collected on study 20201-01 Page 14

                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                    SpeciesStrain MICETGAC HEMI Lab BAT

                    0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                    ANIMAL ID 720 NGKG

                    0 0 3 4 1

                    0 0 3 4 2

                    0 0 3 4 3

                    0 0 3 4 4

                    0 0 3 4 5

                    0 0 3 4 6

                    0 0 3 4 7

                    0 0 3 4 8

                    0 0 3 4 9

                    0 0 3 5 0

                    0 0 3 5 1

                    0 0 3 5 2

                    0 0 3 5 3

                    0 0 3 5 4

                    0 0 3 5 5

                    0 0 3 5 6

                    0 0 3 5 7

                    0 0 3 5 8

                    0 0 3 5 9

                    0 0 3 6 0 TOTALS

                    INTEGUMENTARY SYSTEM

                    Skin + + + + + + + 7

                    Squamous Cell Papilloma X 1

                    Squamous Cell Papilloma Multiple X X X 3

                    Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                    Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                    Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                    Keratoacanthoma X 1

                    Spindle Cell Carcinoma X 1

                    Squamous Cell Carcinoma X X X X X 5

                    Squamous Cell Carcinoma Multiple X X X X 4

                    Squamous Cell Papilloma X 1

                    Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

                    Skin Soa No Mass + + + + + + + + + + + + + 13

                    MUSCULOSKELETAL SYSTEM NONE

                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                    Control data contained within this report was collected on study 20201-01 Page 15

                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                    SpeciesStrain MICETGAC HEMI Lab BAT

                    0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                    0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                    ANIMAL ID 720 NGKG

                    NERVOUS SYSTEM NONE

                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                    RESPIRATORY SYSTEM

                    Lung + + + + + + + + + + + + + + + + + + + + 20

                    AlveolarBronchiolar Adenoma X 1

                    Leukemia Erythrocytic X 1

                    Squamous Cell Carcinoma Metastatic X 1 Skin

                    SPECIAL SENSES SYSTEM NONE

                    URINARY SYSTEM NONE

                    SYSTEMIC LESIONS

                    Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                    Control data contained within this report was collected on study 20201-01 Page 16

                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                    SpeciesStrain MICETGAC HEMI Lab BAT

                    1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                    5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                    ANIMAL ID 1520 NGKG

                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                    ALIMENTARY SYSTEM

                    Liver + + + + + + + + + + + + + + + + + + + + 20

                    Leukemia Granulocytic X 1

                    Stomach Forestomach + + + + + + + + 8

                    Squamous Cell Papilloma X X X X 4

                    Squamous Cell Papilloma Multiple X X X X 4

                    Tooth + + 2

                    Odontogenic Tumor X X 2

                    CARDIOVASCULAR SYSTEM

                    Blood Vessel + 1

                    Heart + 1

                    ENDOCRINE SYSTEM

                    Adrenal Cortex + 1

                    Adrenal Medulla + 1

                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                    Control data contained within this report was collected on study 20201-01 Page 17

                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                    SpeciesStrain MICETGAC HEMI Lab BAT

                    1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                    5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                    ANIMAL ID 1520 NGKG

                    GENERAL BODY SYSTEM NONE

                    GENITAL SYSTEM NONE

                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                    HEMATOPOIETIC SYSTEM

                    Bone Marrow + 1

                    Lymph Node + + + + 4

                    Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                    Squamous Cell Carcinoma Metastatic X X X 3 Skin

                    Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

                    Lymph Node Mandibular + + + 3

                    Squamous Cell Carcinoma Metastatic X 1 Skin

                    Lymph Node Mesenteric + 1

                    Spleen + + + + + + + + + + + + + + + + + + + + 20

                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                    Control data contained within this report was collected on study 20201-01 Page 18

                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                    SpeciesStrain MICETGAC HEMI Lab BAT

                    1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                    5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                    ANIMAL ID 1520 NGKG

                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                    Leukemia Granulocytic X 1

                    Thymus + + + M + + + + + + + + + + + M + + + + 18

                    INTEGUMENTARY SYSTEM

                    Skin + + + + + + + + + + + + + 13

                    Squamous Cell Papilloma X X X X X X X 7

                    Squamous Cell Papilloma Multiple X X X X X 5

                    Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                    Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                    Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                    Spindle Cell Carcinoma X X X 3

                    Spindle Cell Carcinoma Multiple X 1

                    Squamous Cell Carcinoma X X X X X 5

                    Squamous Cell Carcinoma Multiple X X X X X X X 7

                    Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

                    Skin Soa No Mass + + + + + + + + + + + + 12

                    MUSCULOSKELETAL SYSTEM

                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                    Control data contained within this report was collected on study 20201-01 Page 19

                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                    SpeciesStrain MICETGAC HEMI Lab BAT

                    1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                    5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                    ANIMAL ID 1520 NGKG

                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                    Bone + 1

                    NERVOUS SYSTEM

                    Brain + 1

                    RESPIRATORY SYSTEM

                    Lung + + + + + + + + + + + + + + + + + + + + 20

                    AlveolarBronchiolar Adenoma X 1

                    Leukemia Granulocytic X 1

                    Squamous Cell Carcinoma Metastatic X X 2 Skin

                    SPECIAL SENSES SYSTEM

                    Eye + 1

                    URINARY SYSTEM

                    Kidney + 1

                    Leukemia Granulocytic X 1

                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                    Control data contained within this report was collected on study 20201-01 Page 20

                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                    SpeciesStrain MICETGAC HEMI Lab BAT

                    1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                    5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                    ANIMAL ID 1520 NGKG

                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                    SYSTEMIC LESIONS

                    Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

                    Myelodysplasia X 1

                    END OF REPORT

                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                    Control data contained within this report was collected on study 20201-01 Page 21

                    • TDMS No 20201 -03 P0413
                    • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
                    • END OF REPORT

                      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                      SpeciesStrain MICETGAC HEMI Lab BAT

                      1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

                      3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

                      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                      ANIMAL ID 242 NGKG

                      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                      HEMATOPOIETIC SYSTEM

                      Spleen + + + + + + + + + + + + + + + + + + + + 20

                      Thymus + + + M + + + + + + + + + + + + + + + + 19

                      INTEGUMENTARY SYSTEM

                      Skin + + + + + + + + 8

                      Squamous Cell Papilloma X X X 3

                      Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                      Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                      Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                      Spindle Cell Carcinoma X 1

                      Squamous Cell Carcinoma X X 2

                      Squamous Cell Papilloma X 1

                      Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16

                      Skin Soa No Mass + + + + + + + + + + + + + + + + + 17

                      MUSCULOSKELETAL SYSTEM

                      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                      Control data contained within this report was collected on study 20201-01 Page 11

                      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                      SpeciesStrain MICETGAC HEMI Lab BAT

                      1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

                      3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

                      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                      ANIMAL ID 242 NGKG

                      NONE

                      NERVOUS SYSTEM NONE

                      RESPIRATORY SYSTEM

                      Lung

                      + + + + + + + + + + + + + + + + + + + + 20

                      SPECIAL SENSES SYSTEM NONE

                      URINARY SYSTEM NONE

                      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                      SYSTEMIC LESIONS

                      Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

                      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                      Control data contained within this report was collected on study 20201-01 Page 12

                      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                      SpeciesStrain MICETGAC HEMI Lab BAT

                      0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                      0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                      ANIMAL ID 720 NGKG

                      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                      ALIMENTARY SYSTEM

                      Liver + + + + + + + + + + + + + + + + + + + + 20

                      Leukemia Erythrocytic X 1

                      Stomach Forestomach + + + + + 5

                      Squamous Cell Papilloma X X X X X 5

                      Tooth + 1

                      CARDIOVASCULAR SYSTEM NONE

                      ENDOCRINE SYSTEM

                      Pituitary Gland

                      Leukemia Erythrocytic

                      + 1 X 1

                      GENERAL BODY SYSTEM NONE

                      GENITAL SYSTEM NONE

                      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                      Control data contained within this report was collected on study 20201-01 Page 13

                      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                      SpeciesStrain MICETGAC HEMI Lab BAT

                      0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                      0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                      ANIMAL ID 720 NGKG

                      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                      HEMATOPOIETIC SYSTEM

                      Lymph Node + + + + + + + + 8

                      Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                      Squamous Cell Carcinoma Metastatic X 1 Lymph Node

                      Squamous Cell Carcinoma Metastatic X X X 3 Skin

                      Lumbar Leukemia Erythrocytic X 1

                      Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin

                      Renal Leukemia Erythrocytic X 1

                      Lymph Node Mandibular + + + 3

                      Leukemia Erythrocytic X 1

                      Squamous Cell Carcinoma Metastatic X 1 Skin

                      Lymph Node Mesenteric + + 2

                      Spleen + + + + + + + + + + + + + + + + + + + + 20

                      Leukemia Erythrocytic X 1

                      Thymus + + + + + + + + + + + + + + + + + + + M 19

                      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                      Control data contained within this report was collected on study 20201-01 Page 14

                      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                      SpeciesStrain MICETGAC HEMI Lab BAT

                      0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                      ANIMAL ID 720 NGKG

                      0 0 3 4 1

                      0 0 3 4 2

                      0 0 3 4 3

                      0 0 3 4 4

                      0 0 3 4 5

                      0 0 3 4 6

                      0 0 3 4 7

                      0 0 3 4 8

                      0 0 3 4 9

                      0 0 3 5 0

                      0 0 3 5 1

                      0 0 3 5 2

                      0 0 3 5 3

                      0 0 3 5 4

                      0 0 3 5 5

                      0 0 3 5 6

                      0 0 3 5 7

                      0 0 3 5 8

                      0 0 3 5 9

                      0 0 3 6 0 TOTALS

                      INTEGUMENTARY SYSTEM

                      Skin + + + + + + + 7

                      Squamous Cell Papilloma X 1

                      Squamous Cell Papilloma Multiple X X X 3

                      Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                      Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                      Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                      Keratoacanthoma X 1

                      Spindle Cell Carcinoma X 1

                      Squamous Cell Carcinoma X X X X X 5

                      Squamous Cell Carcinoma Multiple X X X X 4

                      Squamous Cell Papilloma X 1

                      Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

                      Skin Soa No Mass + + + + + + + + + + + + + 13

                      MUSCULOSKELETAL SYSTEM NONE

                      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                      Control data contained within this report was collected on study 20201-01 Page 15

                      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                      SpeciesStrain MICETGAC HEMI Lab BAT

                      0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                      0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                      ANIMAL ID 720 NGKG

                      NERVOUS SYSTEM NONE

                      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                      RESPIRATORY SYSTEM

                      Lung + + + + + + + + + + + + + + + + + + + + 20

                      AlveolarBronchiolar Adenoma X 1

                      Leukemia Erythrocytic X 1

                      Squamous Cell Carcinoma Metastatic X 1 Skin

                      SPECIAL SENSES SYSTEM NONE

                      URINARY SYSTEM NONE

                      SYSTEMIC LESIONS

                      Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

                      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                      Control data contained within this report was collected on study 20201-01 Page 16

                      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                      SpeciesStrain MICETGAC HEMI Lab BAT

                      1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                      5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                      ANIMAL ID 1520 NGKG

                      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                      ALIMENTARY SYSTEM

                      Liver + + + + + + + + + + + + + + + + + + + + 20

                      Leukemia Granulocytic X 1

                      Stomach Forestomach + + + + + + + + 8

                      Squamous Cell Papilloma X X X X 4

                      Squamous Cell Papilloma Multiple X X X X 4

                      Tooth + + 2

                      Odontogenic Tumor X X 2

                      CARDIOVASCULAR SYSTEM

                      Blood Vessel + 1

                      Heart + 1

                      ENDOCRINE SYSTEM

                      Adrenal Cortex + 1

                      Adrenal Medulla + 1

                      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                      Control data contained within this report was collected on study 20201-01 Page 17

                      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                      SpeciesStrain MICETGAC HEMI Lab BAT

                      1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                      5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                      ANIMAL ID 1520 NGKG

                      GENERAL BODY SYSTEM NONE

                      GENITAL SYSTEM NONE

                      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                      HEMATOPOIETIC SYSTEM

                      Bone Marrow + 1

                      Lymph Node + + + + 4

                      Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                      Squamous Cell Carcinoma Metastatic X X X 3 Skin

                      Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

                      Lymph Node Mandibular + + + 3

                      Squamous Cell Carcinoma Metastatic X 1 Skin

                      Lymph Node Mesenteric + 1

                      Spleen + + + + + + + + + + + + + + + + + + + + 20

                      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                      Control data contained within this report was collected on study 20201-01 Page 18

                      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                      SpeciesStrain MICETGAC HEMI Lab BAT

                      1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                      5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                      ANIMAL ID 1520 NGKG

                      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                      Leukemia Granulocytic X 1

                      Thymus + + + M + + + + + + + + + + + M + + + + 18

                      INTEGUMENTARY SYSTEM

                      Skin + + + + + + + + + + + + + 13

                      Squamous Cell Papilloma X X X X X X X 7

                      Squamous Cell Papilloma Multiple X X X X X 5

                      Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                      Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                      Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                      Spindle Cell Carcinoma X X X 3

                      Spindle Cell Carcinoma Multiple X 1

                      Squamous Cell Carcinoma X X X X X 5

                      Squamous Cell Carcinoma Multiple X X X X X X X 7

                      Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

                      Skin Soa No Mass + + + + + + + + + + + + 12

                      MUSCULOSKELETAL SYSTEM

                      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                      Control data contained within this report was collected on study 20201-01 Page 19

                      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                      SpeciesStrain MICETGAC HEMI Lab BAT

                      1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                      5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                      ANIMAL ID 1520 NGKG

                      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                      Bone + 1

                      NERVOUS SYSTEM

                      Brain + 1

                      RESPIRATORY SYSTEM

                      Lung + + + + + + + + + + + + + + + + + + + + 20

                      AlveolarBronchiolar Adenoma X 1

                      Leukemia Granulocytic X 1

                      Squamous Cell Carcinoma Metastatic X X 2 Skin

                      SPECIAL SENSES SYSTEM

                      Eye + 1

                      URINARY SYSTEM

                      Kidney + 1

                      Leukemia Granulocytic X 1

                      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                      Control data contained within this report was collected on study 20201-01 Page 20

                      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                      SpeciesStrain MICETGAC HEMI Lab BAT

                      1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                      5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                      ANIMAL ID 1520 NGKG

                      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                      SYSTEMIC LESIONS

                      Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

                      Myelodysplasia X 1

                      END OF REPORT

                      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                      Control data contained within this report was collected on study 20201-01 Page 21

                      • TDMS No 20201 -03 P0413
                      • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
                      • END OF REPORT

                        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                        SpeciesStrain MICETGAC HEMI Lab BAT

                        1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 4 7 8 1 8 8 8 8 8 8 8 2 8 8 8 8 8 8 8 8

                        3 1 5 4 5 3 6 6 6 4 6 7 5 4 4 6 3 4 5 7

                        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                        ANIMAL ID 242 NGKG

                        NONE

                        NERVOUS SYSTEM NONE

                        RESPIRATORY SYSTEM

                        Lung

                        + + + + + + + + + + + + + + + + + + + + 20

                        SPECIAL SENSES SYSTEM NONE

                        URINARY SYSTEM NONE

                        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                        SYSTEMIC LESIONS

                        Multiple Organ + + + + + + + + + + + + + + + + + + + + 20

                        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                        Control data contained within this report was collected on study 20201-01 Page 12

                        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                        SpeciesStrain MICETGAC HEMI Lab BAT

                        0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                        0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                        ANIMAL ID 720 NGKG

                        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                        ALIMENTARY SYSTEM

                        Liver + + + + + + + + + + + + + + + + + + + + 20

                        Leukemia Erythrocytic X 1

                        Stomach Forestomach + + + + + 5

                        Squamous Cell Papilloma X X X X X 5

                        Tooth + 1

                        CARDIOVASCULAR SYSTEM NONE

                        ENDOCRINE SYSTEM

                        Pituitary Gland

                        Leukemia Erythrocytic

                        + 1 X 1

                        GENERAL BODY SYSTEM NONE

                        GENITAL SYSTEM NONE

                        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                        Control data contained within this report was collected on study 20201-01 Page 13

                        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                        SpeciesStrain MICETGAC HEMI Lab BAT

                        0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                        0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                        ANIMAL ID 720 NGKG

                        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                        HEMATOPOIETIC SYSTEM

                        Lymph Node + + + + + + + + 8

                        Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                        Squamous Cell Carcinoma Metastatic X 1 Lymph Node

                        Squamous Cell Carcinoma Metastatic X X X 3 Skin

                        Lumbar Leukemia Erythrocytic X 1

                        Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin

                        Renal Leukemia Erythrocytic X 1

                        Lymph Node Mandibular + + + 3

                        Leukemia Erythrocytic X 1

                        Squamous Cell Carcinoma Metastatic X 1 Skin

                        Lymph Node Mesenteric + + 2

                        Spleen + + + + + + + + + + + + + + + + + + + + 20

                        Leukemia Erythrocytic X 1

                        Thymus + + + + + + + + + + + + + + + + + + + M 19

                        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                        Control data contained within this report was collected on study 20201-01 Page 14

                        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                        SpeciesStrain MICETGAC HEMI Lab BAT

                        0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                        ANIMAL ID 720 NGKG

                        0 0 3 4 1

                        0 0 3 4 2

                        0 0 3 4 3

                        0 0 3 4 4

                        0 0 3 4 5

                        0 0 3 4 6

                        0 0 3 4 7

                        0 0 3 4 8

                        0 0 3 4 9

                        0 0 3 5 0

                        0 0 3 5 1

                        0 0 3 5 2

                        0 0 3 5 3

                        0 0 3 5 4

                        0 0 3 5 5

                        0 0 3 5 6

                        0 0 3 5 7

                        0 0 3 5 8

                        0 0 3 5 9

                        0 0 3 6 0 TOTALS

                        INTEGUMENTARY SYSTEM

                        Skin + + + + + + + 7

                        Squamous Cell Papilloma X 1

                        Squamous Cell Papilloma Multiple X X X 3

                        Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                        Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                        Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                        Keratoacanthoma X 1

                        Spindle Cell Carcinoma X 1

                        Squamous Cell Carcinoma X X X X X 5

                        Squamous Cell Carcinoma Multiple X X X X 4

                        Squamous Cell Papilloma X 1

                        Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

                        Skin Soa No Mass + + + + + + + + + + + + + 13

                        MUSCULOSKELETAL SYSTEM NONE

                        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                        Control data contained within this report was collected on study 20201-01 Page 15

                        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                        SpeciesStrain MICETGAC HEMI Lab BAT

                        0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                        0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                        ANIMAL ID 720 NGKG

                        NERVOUS SYSTEM NONE

                        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                        RESPIRATORY SYSTEM

                        Lung + + + + + + + + + + + + + + + + + + + + 20

                        AlveolarBronchiolar Adenoma X 1

                        Leukemia Erythrocytic X 1

                        Squamous Cell Carcinoma Metastatic X 1 Skin

                        SPECIAL SENSES SYSTEM NONE

                        URINARY SYSTEM NONE

                        SYSTEMIC LESIONS

                        Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

                        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                        Control data contained within this report was collected on study 20201-01 Page 16

                        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                        SpeciesStrain MICETGAC HEMI Lab BAT

                        1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                        5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                        ANIMAL ID 1520 NGKG

                        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                        ALIMENTARY SYSTEM

                        Liver + + + + + + + + + + + + + + + + + + + + 20

                        Leukemia Granulocytic X 1

                        Stomach Forestomach + + + + + + + + 8

                        Squamous Cell Papilloma X X X X 4

                        Squamous Cell Papilloma Multiple X X X X 4

                        Tooth + + 2

                        Odontogenic Tumor X X 2

                        CARDIOVASCULAR SYSTEM

                        Blood Vessel + 1

                        Heart + 1

                        ENDOCRINE SYSTEM

                        Adrenal Cortex + 1

                        Adrenal Medulla + 1

                        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                        Control data contained within this report was collected on study 20201-01 Page 17

                        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                        SpeciesStrain MICETGAC HEMI Lab BAT

                        1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                        5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                        ANIMAL ID 1520 NGKG

                        GENERAL BODY SYSTEM NONE

                        GENITAL SYSTEM NONE

                        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                        HEMATOPOIETIC SYSTEM

                        Bone Marrow + 1

                        Lymph Node + + + + 4

                        Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                        Squamous Cell Carcinoma Metastatic X X X 3 Skin

                        Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

                        Lymph Node Mandibular + + + 3

                        Squamous Cell Carcinoma Metastatic X 1 Skin

                        Lymph Node Mesenteric + 1

                        Spleen + + + + + + + + + + + + + + + + + + + + 20

                        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                        Control data contained within this report was collected on study 20201-01 Page 18

                        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                        SpeciesStrain MICETGAC HEMI Lab BAT

                        1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                        5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                        ANIMAL ID 1520 NGKG

                        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                        Leukemia Granulocytic X 1

                        Thymus + + + M + + + + + + + + + + + M + + + + 18

                        INTEGUMENTARY SYSTEM

                        Skin + + + + + + + + + + + + + 13

                        Squamous Cell Papilloma X X X X X X X 7

                        Squamous Cell Papilloma Multiple X X X X X 5

                        Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                        Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                        Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                        Spindle Cell Carcinoma X X X 3

                        Spindle Cell Carcinoma Multiple X 1

                        Squamous Cell Carcinoma X X X X X 5

                        Squamous Cell Carcinoma Multiple X X X X X X X 7

                        Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

                        Skin Soa No Mass + + + + + + + + + + + + 12

                        MUSCULOSKELETAL SYSTEM

                        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                        Control data contained within this report was collected on study 20201-01 Page 19

                        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                        SpeciesStrain MICETGAC HEMI Lab BAT

                        1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                        5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                        ANIMAL ID 1520 NGKG

                        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                        Bone + 1

                        NERVOUS SYSTEM

                        Brain + 1

                        RESPIRATORY SYSTEM

                        Lung + + + + + + + + + + + + + + + + + + + + 20

                        AlveolarBronchiolar Adenoma X 1

                        Leukemia Granulocytic X 1

                        Squamous Cell Carcinoma Metastatic X X 2 Skin

                        SPECIAL SENSES SYSTEM

                        Eye + 1

                        URINARY SYSTEM

                        Kidney + 1

                        Leukemia Granulocytic X 1

                        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                        Control data contained within this report was collected on study 20201-01 Page 20

                        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                        SpeciesStrain MICETGAC HEMI Lab BAT

                        1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                        5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                        ANIMAL ID 1520 NGKG

                        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                        SYSTEMIC LESIONS

                        Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

                        Myelodysplasia X 1

                        END OF REPORT

                        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                        Control data contained within this report was collected on study 20201-01 Page 21

                        • TDMS No 20201 -03 P0413
                        • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
                        • END OF REPORT

                          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                          SpeciesStrain MICETGAC HEMI Lab BAT

                          0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                          0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                          ANIMAL ID 720 NGKG

                          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                          ALIMENTARY SYSTEM

                          Liver + + + + + + + + + + + + + + + + + + + + 20

                          Leukemia Erythrocytic X 1

                          Stomach Forestomach + + + + + 5

                          Squamous Cell Papilloma X X X X X 5

                          Tooth + 1

                          CARDIOVASCULAR SYSTEM NONE

                          ENDOCRINE SYSTEM

                          Pituitary Gland

                          Leukemia Erythrocytic

                          + 1 X 1

                          GENERAL BODY SYSTEM NONE

                          GENITAL SYSTEM NONE

                          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                          Control data contained within this report was collected on study 20201-01 Page 13

                          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                          SpeciesStrain MICETGAC HEMI Lab BAT

                          0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                          0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                          ANIMAL ID 720 NGKG

                          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                          HEMATOPOIETIC SYSTEM

                          Lymph Node + + + + + + + + 8

                          Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                          Squamous Cell Carcinoma Metastatic X 1 Lymph Node

                          Squamous Cell Carcinoma Metastatic X X X 3 Skin

                          Lumbar Leukemia Erythrocytic X 1

                          Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin

                          Renal Leukemia Erythrocytic X 1

                          Lymph Node Mandibular + + + 3

                          Leukemia Erythrocytic X 1

                          Squamous Cell Carcinoma Metastatic X 1 Skin

                          Lymph Node Mesenteric + + 2

                          Spleen + + + + + + + + + + + + + + + + + + + + 20

                          Leukemia Erythrocytic X 1

                          Thymus + + + + + + + + + + + + + + + + + + + M 19

                          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                          Control data contained within this report was collected on study 20201-01 Page 14

                          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                          SpeciesStrain MICETGAC HEMI Lab BAT

                          0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                          ANIMAL ID 720 NGKG

                          0 0 3 4 1

                          0 0 3 4 2

                          0 0 3 4 3

                          0 0 3 4 4

                          0 0 3 4 5

                          0 0 3 4 6

                          0 0 3 4 7

                          0 0 3 4 8

                          0 0 3 4 9

                          0 0 3 5 0

                          0 0 3 5 1

                          0 0 3 5 2

                          0 0 3 5 3

                          0 0 3 5 4

                          0 0 3 5 5

                          0 0 3 5 6

                          0 0 3 5 7

                          0 0 3 5 8

                          0 0 3 5 9

                          0 0 3 6 0 TOTALS

                          INTEGUMENTARY SYSTEM

                          Skin + + + + + + + 7

                          Squamous Cell Papilloma X 1

                          Squamous Cell Papilloma Multiple X X X 3

                          Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                          Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                          Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                          Keratoacanthoma X 1

                          Spindle Cell Carcinoma X 1

                          Squamous Cell Carcinoma X X X X X 5

                          Squamous Cell Carcinoma Multiple X X X X 4

                          Squamous Cell Papilloma X 1

                          Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

                          Skin Soa No Mass + + + + + + + + + + + + + 13

                          MUSCULOSKELETAL SYSTEM NONE

                          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                          Control data contained within this report was collected on study 20201-01 Page 15

                          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                          SpeciesStrain MICETGAC HEMI Lab BAT

                          0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                          0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                          ANIMAL ID 720 NGKG

                          NERVOUS SYSTEM NONE

                          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                          RESPIRATORY SYSTEM

                          Lung + + + + + + + + + + + + + + + + + + + + 20

                          AlveolarBronchiolar Adenoma X 1

                          Leukemia Erythrocytic X 1

                          Squamous Cell Carcinoma Metastatic X 1 Skin

                          SPECIAL SENSES SYSTEM NONE

                          URINARY SYSTEM NONE

                          SYSTEMIC LESIONS

                          Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

                          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                          Control data contained within this report was collected on study 20201-01 Page 16

                          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                          SpeciesStrain MICETGAC HEMI Lab BAT

                          1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                          5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                          ANIMAL ID 1520 NGKG

                          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                          ALIMENTARY SYSTEM

                          Liver + + + + + + + + + + + + + + + + + + + + 20

                          Leukemia Granulocytic X 1

                          Stomach Forestomach + + + + + + + + 8

                          Squamous Cell Papilloma X X X X 4

                          Squamous Cell Papilloma Multiple X X X X 4

                          Tooth + + 2

                          Odontogenic Tumor X X 2

                          CARDIOVASCULAR SYSTEM

                          Blood Vessel + 1

                          Heart + 1

                          ENDOCRINE SYSTEM

                          Adrenal Cortex + 1

                          Adrenal Medulla + 1

                          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                          Control data contained within this report was collected on study 20201-01 Page 17

                          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                          SpeciesStrain MICETGAC HEMI Lab BAT

                          1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                          5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                          ANIMAL ID 1520 NGKG

                          GENERAL BODY SYSTEM NONE

                          GENITAL SYSTEM NONE

                          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                          HEMATOPOIETIC SYSTEM

                          Bone Marrow + 1

                          Lymph Node + + + + 4

                          Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                          Squamous Cell Carcinoma Metastatic X X X 3 Skin

                          Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

                          Lymph Node Mandibular + + + 3

                          Squamous Cell Carcinoma Metastatic X 1 Skin

                          Lymph Node Mesenteric + 1

                          Spleen + + + + + + + + + + + + + + + + + + + + 20

                          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                          Control data contained within this report was collected on study 20201-01 Page 18

                          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                          SpeciesStrain MICETGAC HEMI Lab BAT

                          1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                          5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                          ANIMAL ID 1520 NGKG

                          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                          Leukemia Granulocytic X 1

                          Thymus + + + M + + + + + + + + + + + M + + + + 18

                          INTEGUMENTARY SYSTEM

                          Skin + + + + + + + + + + + + + 13

                          Squamous Cell Papilloma X X X X X X X 7

                          Squamous Cell Papilloma Multiple X X X X X 5

                          Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                          Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                          Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                          Spindle Cell Carcinoma X X X 3

                          Spindle Cell Carcinoma Multiple X 1

                          Squamous Cell Carcinoma X X X X X 5

                          Squamous Cell Carcinoma Multiple X X X X X X X 7

                          Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

                          Skin Soa No Mass + + + + + + + + + + + + 12

                          MUSCULOSKELETAL SYSTEM

                          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                          Control data contained within this report was collected on study 20201-01 Page 19

                          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                          SpeciesStrain MICETGAC HEMI Lab BAT

                          1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                          5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                          ANIMAL ID 1520 NGKG

                          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                          Bone + 1

                          NERVOUS SYSTEM

                          Brain + 1

                          RESPIRATORY SYSTEM

                          Lung + + + + + + + + + + + + + + + + + + + + 20

                          AlveolarBronchiolar Adenoma X 1

                          Leukemia Granulocytic X 1

                          Squamous Cell Carcinoma Metastatic X X 2 Skin

                          SPECIAL SENSES SYSTEM

                          Eye + 1

                          URINARY SYSTEM

                          Kidney + 1

                          Leukemia Granulocytic X 1

                          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                          Control data contained within this report was collected on study 20201-01 Page 20

                          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                          SpeciesStrain MICETGAC HEMI Lab BAT

                          1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                          5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                          ANIMAL ID 1520 NGKG

                          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                          SYSTEMIC LESIONS

                          Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

                          Myelodysplasia X 1

                          END OF REPORT

                          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                          Control data contained within this report was collected on study 20201-01 Page 21

                          • TDMS No 20201 -03 P0413
                          • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
                          • END OF REPORT

                            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                            SpeciesStrain MICETGAC HEMI Lab BAT

                            0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                            0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                            ANIMAL ID 720 NGKG

                            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                            HEMATOPOIETIC SYSTEM

                            Lymph Node + + + + + + + + 8

                            Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                            Squamous Cell Carcinoma Metastatic X 1 Lymph Node

                            Squamous Cell Carcinoma Metastatic X X X 3 Skin

                            Lumbar Leukemia Erythrocytic X 1

                            Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin

                            Renal Leukemia Erythrocytic X 1

                            Lymph Node Mandibular + + + 3

                            Leukemia Erythrocytic X 1

                            Squamous Cell Carcinoma Metastatic X 1 Skin

                            Lymph Node Mesenteric + + 2

                            Spleen + + + + + + + + + + + + + + + + + + + + 20

                            Leukemia Erythrocytic X 1

                            Thymus + + + + + + + + + + + + + + + + + + + M 19

                            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                            Control data contained within this report was collected on study 20201-01 Page 14

                            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                            SpeciesStrain MICETGAC HEMI Lab BAT

                            0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                            ANIMAL ID 720 NGKG

                            0 0 3 4 1

                            0 0 3 4 2

                            0 0 3 4 3

                            0 0 3 4 4

                            0 0 3 4 5

                            0 0 3 4 6

                            0 0 3 4 7

                            0 0 3 4 8

                            0 0 3 4 9

                            0 0 3 5 0

                            0 0 3 5 1

                            0 0 3 5 2

                            0 0 3 5 3

                            0 0 3 5 4

                            0 0 3 5 5

                            0 0 3 5 6

                            0 0 3 5 7

                            0 0 3 5 8

                            0 0 3 5 9

                            0 0 3 6 0 TOTALS

                            INTEGUMENTARY SYSTEM

                            Skin + + + + + + + 7

                            Squamous Cell Papilloma X 1

                            Squamous Cell Papilloma Multiple X X X 3

                            Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                            Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                            Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                            Keratoacanthoma X 1

                            Spindle Cell Carcinoma X 1

                            Squamous Cell Carcinoma X X X X X 5

                            Squamous Cell Carcinoma Multiple X X X X 4

                            Squamous Cell Papilloma X 1

                            Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

                            Skin Soa No Mass + + + + + + + + + + + + + 13

                            MUSCULOSKELETAL SYSTEM NONE

                            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                            Control data contained within this report was collected on study 20201-01 Page 15

                            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                            SpeciesStrain MICETGAC HEMI Lab BAT

                            0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                            0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                            ANIMAL ID 720 NGKG

                            NERVOUS SYSTEM NONE

                            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                            RESPIRATORY SYSTEM

                            Lung + + + + + + + + + + + + + + + + + + + + 20

                            AlveolarBronchiolar Adenoma X 1

                            Leukemia Erythrocytic X 1

                            Squamous Cell Carcinoma Metastatic X 1 Skin

                            SPECIAL SENSES SYSTEM NONE

                            URINARY SYSTEM NONE

                            SYSTEMIC LESIONS

                            Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

                            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                            Control data contained within this report was collected on study 20201-01 Page 16

                            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                            SpeciesStrain MICETGAC HEMI Lab BAT

                            1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                            5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                            ANIMAL ID 1520 NGKG

                            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                            ALIMENTARY SYSTEM

                            Liver + + + + + + + + + + + + + + + + + + + + 20

                            Leukemia Granulocytic X 1

                            Stomach Forestomach + + + + + + + + 8

                            Squamous Cell Papilloma X X X X 4

                            Squamous Cell Papilloma Multiple X X X X 4

                            Tooth + + 2

                            Odontogenic Tumor X X 2

                            CARDIOVASCULAR SYSTEM

                            Blood Vessel + 1

                            Heart + 1

                            ENDOCRINE SYSTEM

                            Adrenal Cortex + 1

                            Adrenal Medulla + 1

                            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                            Control data contained within this report was collected on study 20201-01 Page 17

                            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                            SpeciesStrain MICETGAC HEMI Lab BAT

                            1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                            5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                            ANIMAL ID 1520 NGKG

                            GENERAL BODY SYSTEM NONE

                            GENITAL SYSTEM NONE

                            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                            HEMATOPOIETIC SYSTEM

                            Bone Marrow + 1

                            Lymph Node + + + + 4

                            Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                            Squamous Cell Carcinoma Metastatic X X X 3 Skin

                            Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

                            Lymph Node Mandibular + + + 3

                            Squamous Cell Carcinoma Metastatic X 1 Skin

                            Lymph Node Mesenteric + 1

                            Spleen + + + + + + + + + + + + + + + + + + + + 20

                            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                            Control data contained within this report was collected on study 20201-01 Page 18

                            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                            SpeciesStrain MICETGAC HEMI Lab BAT

                            1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                            5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                            ANIMAL ID 1520 NGKG

                            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                            Leukemia Granulocytic X 1

                            Thymus + + + M + + + + + + + + + + + M + + + + 18

                            INTEGUMENTARY SYSTEM

                            Skin + + + + + + + + + + + + + 13

                            Squamous Cell Papilloma X X X X X X X 7

                            Squamous Cell Papilloma Multiple X X X X X 5

                            Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                            Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                            Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                            Spindle Cell Carcinoma X X X 3

                            Spindle Cell Carcinoma Multiple X 1

                            Squamous Cell Carcinoma X X X X X 5

                            Squamous Cell Carcinoma Multiple X X X X X X X 7

                            Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

                            Skin Soa No Mass + + + + + + + + + + + + 12

                            MUSCULOSKELETAL SYSTEM

                            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                            Control data contained within this report was collected on study 20201-01 Page 19

                            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                            SpeciesStrain MICETGAC HEMI Lab BAT

                            1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                            5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                            ANIMAL ID 1520 NGKG

                            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                            Bone + 1

                            NERVOUS SYSTEM

                            Brain + 1

                            RESPIRATORY SYSTEM

                            Lung + + + + + + + + + + + + + + + + + + + + 20

                            AlveolarBronchiolar Adenoma X 1

                            Leukemia Granulocytic X 1

                            Squamous Cell Carcinoma Metastatic X X 2 Skin

                            SPECIAL SENSES SYSTEM

                            Eye + 1

                            URINARY SYSTEM

                            Kidney + 1

                            Leukemia Granulocytic X 1

                            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                            Control data contained within this report was collected on study 20201-01 Page 20

                            TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                            Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                            Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                            SpeciesStrain MICETGAC HEMI Lab BAT

                            1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                            5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                            TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                            ANIMAL ID 1520 NGKG

                            0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                            SYSTEMIC LESIONS

                            Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

                            Myelodysplasia X 1

                            END OF REPORT

                            Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                            Control data contained within this report was collected on study 20201-01 Page 21

                            • TDMS No 20201 -03 P0413
                            • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
                            • END OF REPORT

                              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                              SpeciesStrain MICETGAC HEMI Lab BAT

                              0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4DAY ON TEST 0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                              ANIMAL ID 720 NGKG

                              0 0 3 4 1

                              0 0 3 4 2

                              0 0 3 4 3

                              0 0 3 4 4

                              0 0 3 4 5

                              0 0 3 4 6

                              0 0 3 4 7

                              0 0 3 4 8

                              0 0 3 4 9

                              0 0 3 5 0

                              0 0 3 5 1

                              0 0 3 5 2

                              0 0 3 5 3

                              0 0 3 5 4

                              0 0 3 5 5

                              0 0 3 5 6

                              0 0 3 5 7

                              0 0 3 5 8

                              0 0 3 5 9

                              0 0 3 6 0 TOTALS

                              INTEGUMENTARY SYSTEM

                              Skin + + + + + + + 7

                              Squamous Cell Papilloma X 1

                              Squamous Cell Papilloma Multiple X X X 3

                              Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                              Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                              Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                              Keratoacanthoma X 1

                              Spindle Cell Carcinoma X 1

                              Squamous Cell Carcinoma X X X X X 5

                              Squamous Cell Carcinoma Multiple X X X X 4

                              Squamous Cell Papilloma X 1

                              Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19

                              Skin Soa No Mass + + + + + + + + + + + + + 13

                              MUSCULOSKELETAL SYSTEM NONE

                              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                              Control data contained within this report was collected on study 20201-01 Page 15

                              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                              SpeciesStrain MICETGAC HEMI Lab BAT

                              0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                              0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                              ANIMAL ID 720 NGKG

                              NERVOUS SYSTEM NONE

                              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                              RESPIRATORY SYSTEM

                              Lung + + + + + + + + + + + + + + + + + + + + 20

                              AlveolarBronchiolar Adenoma X 1

                              Leukemia Erythrocytic X 1

                              Squamous Cell Carcinoma Metastatic X 1 Skin

                              SPECIAL SENSES SYSTEM NONE

                              URINARY SYSTEM NONE

                              SYSTEMIC LESIONS

                              Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

                              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                              Control data contained within this report was collected on study 20201-01 Page 16

                              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                              SpeciesStrain MICETGAC HEMI Lab BAT

                              1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                              5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                              ANIMAL ID 1520 NGKG

                              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                              ALIMENTARY SYSTEM

                              Liver + + + + + + + + + + + + + + + + + + + + 20

                              Leukemia Granulocytic X 1

                              Stomach Forestomach + + + + + + + + 8

                              Squamous Cell Papilloma X X X X 4

                              Squamous Cell Papilloma Multiple X X X X 4

                              Tooth + + 2

                              Odontogenic Tumor X X 2

                              CARDIOVASCULAR SYSTEM

                              Blood Vessel + 1

                              Heart + 1

                              ENDOCRINE SYSTEM

                              Adrenal Cortex + 1

                              Adrenal Medulla + 1

                              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                              Control data contained within this report was collected on study 20201-01 Page 17

                              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                              SpeciesStrain MICETGAC HEMI Lab BAT

                              1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                              5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                              ANIMAL ID 1520 NGKG

                              GENERAL BODY SYSTEM NONE

                              GENITAL SYSTEM NONE

                              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                              HEMATOPOIETIC SYSTEM

                              Bone Marrow + 1

                              Lymph Node + + + + 4

                              Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                              Squamous Cell Carcinoma Metastatic X X X 3 Skin

                              Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

                              Lymph Node Mandibular + + + 3

                              Squamous Cell Carcinoma Metastatic X 1 Skin

                              Lymph Node Mesenteric + 1

                              Spleen + + + + + + + + + + + + + + + + + + + + 20

                              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                              Control data contained within this report was collected on study 20201-01 Page 18

                              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                              SpeciesStrain MICETGAC HEMI Lab BAT

                              1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                              5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                              ANIMAL ID 1520 NGKG

                              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                              Leukemia Granulocytic X 1

                              Thymus + + + M + + + + + + + + + + + M + + + + 18

                              INTEGUMENTARY SYSTEM

                              Skin + + + + + + + + + + + + + 13

                              Squamous Cell Papilloma X X X X X X X 7

                              Squamous Cell Papilloma Multiple X X X X X 5

                              Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                              Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                              Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                              Spindle Cell Carcinoma X X X 3

                              Spindle Cell Carcinoma Multiple X 1

                              Squamous Cell Carcinoma X X X X X 5

                              Squamous Cell Carcinoma Multiple X X X X X X X 7

                              Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

                              Skin Soa No Mass + + + + + + + + + + + + 12

                              MUSCULOSKELETAL SYSTEM

                              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                              Control data contained within this report was collected on study 20201-01 Page 19

                              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                              SpeciesStrain MICETGAC HEMI Lab BAT

                              1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                              5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                              ANIMAL ID 1520 NGKG

                              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                              Bone + 1

                              NERVOUS SYSTEM

                              Brain + 1

                              RESPIRATORY SYSTEM

                              Lung + + + + + + + + + + + + + + + + + + + + 20

                              AlveolarBronchiolar Adenoma X 1

                              Leukemia Granulocytic X 1

                              Squamous Cell Carcinoma Metastatic X X 2 Skin

                              SPECIAL SENSES SYSTEM

                              Eye + 1

                              URINARY SYSTEM

                              Kidney + 1

                              Leukemia Granulocytic X 1

                              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                              Control data contained within this report was collected on study 20201-01 Page 20

                              TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                              Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                              Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                              SpeciesStrain MICETGAC HEMI Lab BAT

                              1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                              5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                              TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                              ANIMAL ID 1520 NGKG

                              0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                              SYSTEMIC LESIONS

                              Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

                              Myelodysplasia X 1

                              END OF REPORT

                              Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                              Control data contained within this report was collected on study 20201-01 Page 21

                              • TDMS No 20201 -03 P0413
                              • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
                              • END OF REPORT

                                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                SpeciesStrain MICETGAC HEMI Lab BAT

                                0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 6 8 6 8 8 8 8 8 8 2 8 8 8 8 5 8 8 8 4

                                0 3 3 3 3 4 6 3 5 7 2 5 4 7 7 5 3 4 3 3

                                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                ANIMAL ID 720 NGKG

                                NERVOUS SYSTEM NONE

                                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                RESPIRATORY SYSTEM

                                Lung + + + + + + + + + + + + + + + + + + + + 20

                                AlveolarBronchiolar Adenoma X 1

                                Leukemia Erythrocytic X 1

                                Squamous Cell Carcinoma Metastatic X 1 Skin

                                SPECIAL SENSES SYSTEM NONE

                                URINARY SYSTEM NONE

                                SYSTEMIC LESIONS

                                Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Erythrocytic X 1

                                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                Control data contained within this report was collected on study 20201-01 Page 16

                                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                SpeciesStrain MICETGAC HEMI Lab BAT

                                1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                ANIMAL ID 1520 NGKG

                                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                ALIMENTARY SYSTEM

                                Liver + + + + + + + + + + + + + + + + + + + + 20

                                Leukemia Granulocytic X 1

                                Stomach Forestomach + + + + + + + + 8

                                Squamous Cell Papilloma X X X X 4

                                Squamous Cell Papilloma Multiple X X X X 4

                                Tooth + + 2

                                Odontogenic Tumor X X 2

                                CARDIOVASCULAR SYSTEM

                                Blood Vessel + 1

                                Heart + 1

                                ENDOCRINE SYSTEM

                                Adrenal Cortex + 1

                                Adrenal Medulla + 1

                                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                Control data contained within this report was collected on study 20201-01 Page 17

                                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                SpeciesStrain MICETGAC HEMI Lab BAT

                                1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                ANIMAL ID 1520 NGKG

                                GENERAL BODY SYSTEM NONE

                                GENITAL SYSTEM NONE

                                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                HEMATOPOIETIC SYSTEM

                                Bone Marrow + 1

                                Lymph Node + + + + 4

                                Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                                Squamous Cell Carcinoma Metastatic X X X 3 Skin

                                Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

                                Lymph Node Mandibular + + + 3

                                Squamous Cell Carcinoma Metastatic X 1 Skin

                                Lymph Node Mesenteric + 1

                                Spleen + + + + + + + + + + + + + + + + + + + + 20

                                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                Control data contained within this report was collected on study 20201-01 Page 18

                                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                SpeciesStrain MICETGAC HEMI Lab BAT

                                1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                ANIMAL ID 1520 NGKG

                                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                Leukemia Granulocytic X 1

                                Thymus + + + M + + + + + + + + + + + M + + + + 18

                                INTEGUMENTARY SYSTEM

                                Skin + + + + + + + + + + + + + 13

                                Squamous Cell Papilloma X X X X X X X 7

                                Squamous Cell Papilloma Multiple X X X X X 5

                                Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                                Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                                Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                                Spindle Cell Carcinoma X X X 3

                                Spindle Cell Carcinoma Multiple X 1

                                Squamous Cell Carcinoma X X X X X 5

                                Squamous Cell Carcinoma Multiple X X X X X X X 7

                                Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

                                Skin Soa No Mass + + + + + + + + + + + + 12

                                MUSCULOSKELETAL SYSTEM

                                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                Control data contained within this report was collected on study 20201-01 Page 19

                                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                SpeciesStrain MICETGAC HEMI Lab BAT

                                1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                ANIMAL ID 1520 NGKG

                                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                Bone + 1

                                NERVOUS SYSTEM

                                Brain + 1

                                RESPIRATORY SYSTEM

                                Lung + + + + + + + + + + + + + + + + + + + + 20

                                AlveolarBronchiolar Adenoma X 1

                                Leukemia Granulocytic X 1

                                Squamous Cell Carcinoma Metastatic X X 2 Skin

                                SPECIAL SENSES SYSTEM

                                Eye + 1

                                URINARY SYSTEM

                                Kidney + 1

                                Leukemia Granulocytic X 1

                                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                Control data contained within this report was collected on study 20201-01 Page 20

                                TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                SpeciesStrain MICETGAC HEMI Lab BAT

                                1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                ANIMAL ID 1520 NGKG

                                0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                SYSTEMIC LESIONS

                                Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

                                Myelodysplasia X 1

                                END OF REPORT

                                Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                Control data contained within this report was collected on study 20201-01 Page 21

                                • TDMS No 20201 -03 P0413
                                • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
                                • END OF REPORT

                                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                  SpeciesStrain MICETGAC HEMI Lab BAT

                                  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                  5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                  ANIMAL ID 1520 NGKG

                                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                  ALIMENTARY SYSTEM

                                  Liver + + + + + + + + + + + + + + + + + + + + 20

                                  Leukemia Granulocytic X 1

                                  Stomach Forestomach + + + + + + + + 8

                                  Squamous Cell Papilloma X X X X 4

                                  Squamous Cell Papilloma Multiple X X X X 4

                                  Tooth + + 2

                                  Odontogenic Tumor X X 2

                                  CARDIOVASCULAR SYSTEM

                                  Blood Vessel + 1

                                  Heart + 1

                                  ENDOCRINE SYSTEM

                                  Adrenal Cortex + 1

                                  Adrenal Medulla + 1

                                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                  Control data contained within this report was collected on study 20201-01 Page 17

                                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                  SpeciesStrain MICETGAC HEMI Lab BAT

                                  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                  5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                  ANIMAL ID 1520 NGKG

                                  GENERAL BODY SYSTEM NONE

                                  GENITAL SYSTEM NONE

                                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                  HEMATOPOIETIC SYSTEM

                                  Bone Marrow + 1

                                  Lymph Node + + + + 4

                                  Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                                  Squamous Cell Carcinoma Metastatic X X X 3 Skin

                                  Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

                                  Lymph Node Mandibular + + + 3

                                  Squamous Cell Carcinoma Metastatic X 1 Skin

                                  Lymph Node Mesenteric + 1

                                  Spleen + + + + + + + + + + + + + + + + + + + + 20

                                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                  Control data contained within this report was collected on study 20201-01 Page 18

                                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                  SpeciesStrain MICETGAC HEMI Lab BAT

                                  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                  5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                  ANIMAL ID 1520 NGKG

                                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                  Leukemia Granulocytic X 1

                                  Thymus + + + M + + + + + + + + + + + M + + + + 18

                                  INTEGUMENTARY SYSTEM

                                  Skin + + + + + + + + + + + + + 13

                                  Squamous Cell Papilloma X X X X X X X 7

                                  Squamous Cell Papilloma Multiple X X X X X 5

                                  Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                                  Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                                  Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                                  Spindle Cell Carcinoma X X X 3

                                  Spindle Cell Carcinoma Multiple X 1

                                  Squamous Cell Carcinoma X X X X X 5

                                  Squamous Cell Carcinoma Multiple X X X X X X X 7

                                  Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

                                  Skin Soa No Mass + + + + + + + + + + + + 12

                                  MUSCULOSKELETAL SYSTEM

                                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                  Control data contained within this report was collected on study 20201-01 Page 19

                                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                  SpeciesStrain MICETGAC HEMI Lab BAT

                                  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                  5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                  ANIMAL ID 1520 NGKG

                                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                  Bone + 1

                                  NERVOUS SYSTEM

                                  Brain + 1

                                  RESPIRATORY SYSTEM

                                  Lung + + + + + + + + + + + + + + + + + + + + 20

                                  AlveolarBronchiolar Adenoma X 1

                                  Leukemia Granulocytic X 1

                                  Squamous Cell Carcinoma Metastatic X X 2 Skin

                                  SPECIAL SENSES SYSTEM

                                  Eye + 1

                                  URINARY SYSTEM

                                  Kidney + 1

                                  Leukemia Granulocytic X 1

                                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                  Control data contained within this report was collected on study 20201-01 Page 20

                                  TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                  Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                  Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                  SpeciesStrain MICETGAC HEMI Lab BAT

                                  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                  5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                  TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                  ANIMAL ID 1520 NGKG

                                  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                  SYSTEMIC LESIONS

                                  Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

                                  Myelodysplasia X 1

                                  END OF REPORT

                                  Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                  Control data contained within this report was collected on study 20201-01 Page 21

                                  • TDMS No 20201 -03 P0413
                                  • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
                                  • END OF REPORT

                                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                    SpeciesStrain MICETGAC HEMI Lab BAT

                                    1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                    5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                    ANIMAL ID 1520 NGKG

                                    GENERAL BODY SYSTEM NONE

                                    GENITAL SYSTEM NONE

                                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                    HEMATOPOIETIC SYSTEM

                                    Bone Marrow + 1

                                    Lymph Node + + + + 4

                                    Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application

                                    Squamous Cell Carcinoma Metastatic X X X 3 Skin

                                    Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin

                                    Lymph Node Mandibular + + + 3

                                    Squamous Cell Carcinoma Metastatic X 1 Skin

                                    Lymph Node Mesenteric + 1

                                    Spleen + + + + + + + + + + + + + + + + + + + + 20

                                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                    Control data contained within this report was collected on study 20201-01 Page 18

                                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                    SpeciesStrain MICETGAC HEMI Lab BAT

                                    1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                    5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                    ANIMAL ID 1520 NGKG

                                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                    Leukemia Granulocytic X 1

                                    Thymus + + + M + + + + + + + + + + + M + + + + 18

                                    INTEGUMENTARY SYSTEM

                                    Skin + + + + + + + + + + + + + 13

                                    Squamous Cell Papilloma X X X X X X X 7

                                    Squamous Cell Papilloma Multiple X X X X X 5

                                    Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                                    Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                                    Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                                    Spindle Cell Carcinoma X X X 3

                                    Spindle Cell Carcinoma Multiple X 1

                                    Squamous Cell Carcinoma X X X X X 5

                                    Squamous Cell Carcinoma Multiple X X X X X X X 7

                                    Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

                                    Skin Soa No Mass + + + + + + + + + + + + 12

                                    MUSCULOSKELETAL SYSTEM

                                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                    Control data contained within this report was collected on study 20201-01 Page 19

                                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                    SpeciesStrain MICETGAC HEMI Lab BAT

                                    1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                    5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                    ANIMAL ID 1520 NGKG

                                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                    Bone + 1

                                    NERVOUS SYSTEM

                                    Brain + 1

                                    RESPIRATORY SYSTEM

                                    Lung + + + + + + + + + + + + + + + + + + + + 20

                                    AlveolarBronchiolar Adenoma X 1

                                    Leukemia Granulocytic X 1

                                    Squamous Cell Carcinoma Metastatic X X 2 Skin

                                    SPECIAL SENSES SYSTEM

                                    Eye + 1

                                    URINARY SYSTEM

                                    Kidney + 1

                                    Leukemia Granulocytic X 1

                                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                    Control data contained within this report was collected on study 20201-01 Page 20

                                    TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                    Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                    Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                    SpeciesStrain MICETGAC HEMI Lab BAT

                                    1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                    5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                    TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                    ANIMAL ID 1520 NGKG

                                    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                    SYSTEMIC LESIONS

                                    Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

                                    Myelodysplasia X 1

                                    END OF REPORT

                                    Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                    Control data contained within this report was collected on study 20201-01 Page 21

                                    • TDMS No 20201 -03 P0413
                                    • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
                                    • END OF REPORT

                                      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                      SpeciesStrain MICETGAC HEMI Lab BAT

                                      1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                      5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                      ANIMAL ID 1520 NGKG

                                      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                      Leukemia Granulocytic X 1

                                      Thymus + + + M + + + + + + + + + + + M + + + + 18

                                      INTEGUMENTARY SYSTEM

                                      Skin + + + + + + + + + + + + + 13

                                      Squamous Cell Papilloma X X X X X X X 7

                                      Squamous Cell Papilloma Multiple X X X X X 5

                                      Skin Control Dermis + + + + + + + + + + + + + + + + + + + + 20

                                      Skin Control Epidermis + + + + + + + + + + + + + + + + + + + + 20

                                      Skin Site Of Application + + + + + + + + + + + + + + + + + + + + 20

                                      Spindle Cell Carcinoma X X X 3

                                      Spindle Cell Carcinoma Multiple X 1

                                      Squamous Cell Carcinoma X X X X X 5

                                      Squamous Cell Carcinoma Multiple X X X X X X X 7

                                      Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20

                                      Skin Soa No Mass + + + + + + + + + + + + 12

                                      MUSCULOSKELETAL SYSTEM

                                      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                      Control data contained within this report was collected on study 20201-01 Page 19

                                      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                      SpeciesStrain MICETGAC HEMI Lab BAT

                                      1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                      5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                      ANIMAL ID 1520 NGKG

                                      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                      Bone + 1

                                      NERVOUS SYSTEM

                                      Brain + 1

                                      RESPIRATORY SYSTEM

                                      Lung + + + + + + + + + + + + + + + + + + + + 20

                                      AlveolarBronchiolar Adenoma X 1

                                      Leukemia Granulocytic X 1

                                      Squamous Cell Carcinoma Metastatic X X 2 Skin

                                      SPECIAL SENSES SYSTEM

                                      Eye + 1

                                      URINARY SYSTEM

                                      Kidney + 1

                                      Leukemia Granulocytic X 1

                                      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                      Control data contained within this report was collected on study 20201-01 Page 20

                                      TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                      Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                      Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                      SpeciesStrain MICETGAC HEMI Lab BAT

                                      1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                      5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                      TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                      ANIMAL ID 1520 NGKG

                                      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                      SYSTEMIC LESIONS

                                      Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

                                      Myelodysplasia X 1

                                      END OF REPORT

                                      Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                      Control data contained within this report was collected on study 20201-01 Page 21

                                      • TDMS No 20201 -03 P0413
                                      • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
                                      • END OF REPORT

                                        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                        SpeciesStrain MICETGAC HEMI Lab BAT

                                        1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                        5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                        ANIMAL ID 1520 NGKG

                                        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                        Bone + 1

                                        NERVOUS SYSTEM

                                        Brain + 1

                                        RESPIRATORY SYSTEM

                                        Lung + + + + + + + + + + + + + + + + + + + + 20

                                        AlveolarBronchiolar Adenoma X 1

                                        Leukemia Granulocytic X 1

                                        Squamous Cell Carcinoma Metastatic X X 2 Skin

                                        SPECIAL SENSES SYSTEM

                                        Eye + 1

                                        URINARY SYSTEM

                                        Kidney + 1

                                        Leukemia Granulocytic X 1

                                        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                        Control data contained within this report was collected on study 20201-01 Page 20

                                        TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                        Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                        Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                        SpeciesStrain MICETGAC HEMI Lab BAT

                                        1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                        5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                        TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                        ANIMAL ID 1520 NGKG

                                        0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                        SYSTEMIC LESIONS

                                        Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

                                        Myelodysplasia X 1

                                        END OF REPORT

                                        Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                        Control data contained within this report was collected on study 20201-01 Page 21

                                        • TDMS No 20201 -03 P0413
                                        • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
                                        • END OF REPORT

                                          TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006

                                          Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412

                                          Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103

                                          SpeciesStrain MICETGAC HEMI Lab BAT

                                          1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 DAY ON TEST 8 8 8 7 8 5 5 7 5 2 8 8 8 8 8 8 8 8 8 5

                                          5 3 3 5 4 7 7 2 7 1 5 7 5 4 4 3 7 4 3 0

                                          TGAC (FVBN) HEMIZYGOUS MICE FEMALE

                                          ANIMAL ID 1520 NGKG

                                          0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7 7 8 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 TOTALS

                                          SYSTEMIC LESIONS

                                          Multiple Organ + + + + + + + + + + + + + + + + + + + + 20 Leukemia Granulocytic X 1

                                          Myelodysplasia X 1

                                          END OF REPORT

                                          Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue

                                          Control data contained within this report was collected on study 20201-01 Page 21

                                          • TDMS No 20201 -03 P0413
                                          • TGAC (FVBN) HEMIZYGOUS MICE FEMALE
                                          • END OF REPORT

                                            top related